WO2022075297A1 - Food and drink, anti-fatigue agent, and endurance improver - Google Patents

Food and drink, anti-fatigue agent, and endurance improver Download PDF

Info

Publication number
WO2022075297A1
WO2022075297A1 PCT/JP2021/036738 JP2021036738W WO2022075297A1 WO 2022075297 A1 WO2022075297 A1 WO 2022075297A1 JP 2021036738 W JP2021036738 W JP 2021036738W WO 2022075297 A1 WO2022075297 A1 WO 2022075297A1
Authority
WO
WIPO (PCT)
Prior art keywords
lactic acid
fatigue
fructose
food
agent
Prior art date
Application number
PCT/JP2021/036738
Other languages
French (fr)
Japanese (ja)
Inventor
浩彦 中村
史子 齋藤
梨絵 小池
Original Assignee
森永乳業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 森永乳業株式会社 filed Critical 森永乳業株式会社
Priority to JP2022555490A priority Critical patent/JPWO2022075297A1/ja
Publication of WO2022075297A1 publication Critical patent/WO2022075297A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/60Sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/68Acidifying substances
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Definitions

  • the present invention relates to foods and drinks useful for anti-fatigue or endurance improvement, and also relates to anti-fatigue agents and endurance improving agents.
  • Patent Document 1 discloses a food composition for recovering muscle fatigue associated with exercise, which contains hesperidins and a milk fat globules as active ingredients.
  • Non-Patent Document 1 discloses that lactic acid produced in fast muscle is carried to slow muscle and used for ATP production under oxidative conditions.
  • Non-Patent Document 2 reports that high-intensity training increases blood lactate concentration and promotes mitochondrial adaptation, that is, improvement of metabolism.
  • Non-Patent Document 3 reports that lactic acid in blood causes muscle hypertrophy.
  • Non-Patent Documents 1 to 3 brought about by an increase in lactic acid in blood are useful for activating muscle activity and reducing muscle fatigue.
  • Non-Patent Document 4 discloses that when a large amount of fructose is ingested, the blood lactate concentration increases.
  • An object of the present invention is to provide a new food or drink, an anti-fatigue agent, and an endurance improving agent capable of continuously increasing the blood lactic acid concentration.
  • the present invention relates to [1] to [14] exemplified below.
  • [1] A food or drink containing a lactic acid compound and fructose, wherein the content of the lactic acid compound is 3 g or more and 75 g or less in terms of lactic acid, and the content of the fructose is 7 g or more and 150 g or less.
  • lactic acid compound is at least one selected from the group consisting of lactic acid, potassium lactate, calcium lactate, iron lactate, and sodium lactate.
  • [5] Contains lactic acid compounds and fructose, The content of the lactic acid compound is 0.6% by mass or more and 30% by mass or less in terms of lactic acid.
  • An agent for increasing blood lactic acid concentration which contains a lactic acid compound and fructose as active ingredients.
  • An anti-fatigue method comprising a step of administering a lactic acid compound and fructose to a mammal.
  • a method for improving endurance which comprises a step of administering a lactic acid compound and fructose to a mammal.
  • a new food or drink an anti-fatigue agent, an endurance improving agent, a muscle activity improving agent, and a muscle fatigue recovering agent capable of continuously increasing the blood lactic acid concentration. ..
  • the food or drink according to the present invention contains a lactic acid compound and fructose, the content of the lactic acid compound is 3 g or more and 75 g or less in terms of lactic acid, and the content of fructose is 7 g or more. It is 150 g or less.
  • the food and drink preferably has a lactic acid compound content of 5 g or more and 50 g or less, and a fructose content of 20 g or more and 100 g or less.
  • the content of the lactic acid compound in the food and drink is more preferably 15 g or more and 20 g or less in terms of lactic acid, and the fructose content is more preferably 30 g or more and 50 g or less. According to the food and drink according to the present invention, the blood lactic acid concentration of the ingested individual can be continuously increased.
  • the food and drink may be ingested per meal, may be ingested once, or may be ingested in multiple times. When ingested multiple times, it is preferable that at least 3 g of lactic acid compound and at least 7 g of fructose are ingested into the body at the same timing from the viewpoint of increasing the blood lactate concentration more continuously. .. As the same timing as used herein, for example, within 10 minutes is preferable, and within 5 minutes is more preferable. Food and drink may be provided in individual packages.
  • the food or drink composition according to the present invention (hereinafter, also simply referred to as “food and drink composition”) has a lactic acid compound content of 0.6% by mass or more and 30% by mass or less in terms of lactic acid, and a fructose content of 1. It is 4% by mass or more and 60% by mass or less.
  • the fructose content is preferably 30% by mass or less, more preferably 15% by mass or less.
  • the blood lactic acid concentration of the ingested individual can be continuously increased.
  • the food and drink composition can be used, for example, to prepare the above-mentioned food and drink according to the present invention.
  • the lactic acid compound contained in the food or drink and the food or drink composition is preferably one or more selected from the group consisting of lactic acid, potassium lactate, calcium lactate, iron lactate, and sodium lactate.
  • the lactic acid compound contained in the food or drink and the food or drink composition may be lactic acid, lactate, or one added and contained as a material containing these.
  • the fructose contained in the food and drink and the food and drink composition may be fructose or one added and contained as a material containing fructose.
  • the material containing fructose include high fructose syrup, isomerized sugar such as fructose-glucose syrup, and fruit juice.
  • the food and drink and the food and drink composition according to the present invention can continuously increase the blood lactic acid concentration of the ingested individual.
  • To continuously increase the blood lactate concentration of an ingested individual means to increase the blood lactate concentration of the ingested individual at a specific time after ingestion as compared with the case of not ingesting. It means that it has at least one effect of being able to, or being able to maintain a high value for a certain period of time after ingestion. Therefore, the food and drink and the food and drink composition according to the present invention can also be used as a lactic acid concentration increasing agent.
  • the blood lactic acid concentration of the ingested individual achieves a value of, for example, 2 mmol / L or more at rest, or, for example, 2 mmol / L or more.
  • the time to maintain the value can be lengthened, and in the case of exercise, for example, a value of 4 mmol / L or more can be achieved, or the time to maintain a value of, for example, 4 mmol / L or more can be lengthened. The effect of can be expected.
  • Lactic acid in blood is known to act effectively on activating muscle activity and reducing muscle fatigue. Therefore, the food and drink and the food and drink composition according to the present invention can be used both as a muscle activity activator that promotes activation of muscle activity in exercise such as sports and training, and as a muscle fatigue reducing agent that reduces muscle fatigue due to exercise. Can be used.
  • human “exercise” means muscles such as sports, walking, jogging, aerobic exercise, swimming, cycling, etc., which are intentionally and intentionally carried out for health, physical fitness, and enjoyment. It is an activity that uses. Further, in the present specification, “exercise” includes physical activities in daily life such as labor and housework. Activation of muscle activity can improve the amount of exercise, the duration of exercise, and the quality of exercise. That is, when muscle activity is activated, the time of exercise becomes longer instead of fatigue, the distance traveled by exercise increases, the speed during exercise increases, and the movement and sharpness of the body during exercise increase. do. When muscle fatigue is reduced, the degree of fatigue is reduced even if exercise is performed, and recovery is quick even if fatigue is caused by exercise.
  • Foods and drinks and food and drink compositions are preferably taken before, after, or during exercise because they have the effect of activating muscle activity and reducing muscle fatigue.
  • the food and drink and the food and drink composition according to the present invention have an anti-fatigue effect and an endurance-enhancing effect, and when a human takes them, they exhibit an anti-fatigue effect and / or an endurance-improving effect.
  • “Fatigue” refers to a phenomenon in which the function of exercise and mental activity declines as a result of exercise and mental activity, and is broadly classified into physical fatigue and mental fatigue.
  • the anti-fatigue action according to the present invention may be an anti-fatigue action against physical fatigue or an anti-fatigue action against mental fatigue.
  • human “exercise” is as described above.
  • the term “mental activity” in humans refers to mental activity that accompanies human logical comprehension. Specific contents of human mental activities include thinking work, calculation work, computer work, operation of smartphones, and the like. Examples of human mental activities include work and study.
  • the fatigue associated with the above-mentioned mental activity of a human is, for example, a state after one to two hours of continuous work on a personal computer, although there are individual differences.
  • the "anti-fatigue action” is an action of reducing such a “fatigue” state and an action of promoting recovery from the “fatigue” state by eating and drinking the food or drink or the food or drink composition according to the present invention. Alternatively, it refers to the action of preventing "fatigue” and making it less tiring.
  • the "anti-fatigue effect" on physical fatigue is evaluated by confirming, for example, that, as a result of the subject's exercise, the motor function does not decrease or the motor function improves, as in the examples described later. Can be done.
  • the "anti-fatigue effect” on physical fatigue can, for example, activate muscle activity and reduce muscle fatigue as described above. It can also improve exercise performance.
  • the "anti-fatigue effect” on mental activity can be evaluated by, for example, performing a Kraepelin test or ATMT (Advanced Trail Making Test) as in the examples described later.
  • the "anti-fatigue effect” on mental activity can, for example, reduce subjective fatigue.
  • attention, concentration, and memory can be suppressed, maintained, and improved.
  • the Kraepelin test is a continuous addition work originally used for the purpose of mental examination, specifically, it is a work of adding side-by-side single-digit numbers in order, and is a work of advanced mental activity. It can be positioned as work that causes fatigue (mental fatigue, cerebral fatigue, etc.).
  • the Kraepelin test can be used for quantification as a model system for computational power, computer work, continuous thinking, and the like.
  • ATMT is originally used as a mental function test method, and is a visual search task in which the target numbers presented on the touch panel are pressed in order.
  • the search reaction time for each target can be recorded, and the target is re-targeted for each reaction. It can be placed or newly generated. Therefore, it is also possible to measure the working memory and the degree of fatigue during task execution.
  • “Endurance” refers to the ability to continue to perform certain exercises and mental activities
  • “endurance improving action” refers to the action to enhance the ability to continue.
  • the “endurance improving effect” can be confirmed, for example, by extending a certain degree of luck or duration of mental activity, and by confirming that the quality of continuous exercise or mental activity is above a certain level. can.
  • the "endurance improving effect” can be evaluated by confirming that a constant exercise state can be continuously performed as a result of the subject's exercise, for example, as in the examples described later.
  • the "endurance improving effect” on exercise allows, for example, to maintain and improve the performance of continuous exercise.
  • the “endurance improving effect” on mental activity can suppress, maintain, and improve attention, concentration, and memory deterioration in continuous mental activity.
  • the food or drink and the food or drink composition may consist only of a lactic acid compound and fructose, and may contain other components that are permitted to be contained in the food or drink in addition to the lactic acid compound and fructose.
  • the food or drink and the food or drink composition may be in the form of liquid, gel, paste, solid, powder or the like, and may also include tablets, liquid foods and the like.
  • Foods and drinks and food and drink compositions include, for example, flour products, instant foods, processed agricultural products, processed marine products, processed livestock products, milk and dairy products, fats and oils, basic seasonings, complex seasonings and foods, and frozen foods. , Confectionery, gelled foods, beverages, commercial products other than these, and the like.
  • Examples of wheat flour products include bread, macaroni, spaghetti, noodles, cake mix, fried chicken flour, bread crumbs and the like.
  • Examples of instant foods include instant noodles, cup noodles, retort / cooked foods, canned foods, microwave foods, instant soups / stews, instant miso soups / soups, canned soups, freeze / dry foods, and other instant foods.
  • Examples of processed agricultural products include canned agricultural products, canned fruits, jams and marmalades, pickles, boiled beans, dried agricultural products, cereals (processed grain products) and the like.
  • Examples of processed fishery products include canned fishery products, fish hams and sausages, fish paste products, fishery delicacies, and tsukudani.
  • Examples of processed livestock products include canned livestock and pastes, livestock ham and sausage.
  • milk and dairy products include fermented milk, processed milk, milk drinks, yogurts, lactic acid bacteria drinks, cheese, ice creams, prepared milk powders, creams, and other dairy products.
  • fats and oils include butter, margarines, vegetable oils and the like.
  • Examples of the basic seasoning include soy sauce, miso, sauces, processed tomato seasonings, mirin, vinegar and the like.
  • Examples of complex seasonings / foods include cooking mixes, curry ingredients, sauces, dressings, noodle soups, spices, and other complex seasonings.
  • Examples of the frozen food include raw material frozen food, semi-cooked frozen food, and cooked frozen food.
  • Examples of confectionery include caramel, candy, chewing gum, chocolate, cookies, biscuits, cakes, pies, snacks, crackers, Japanese confectionery, rice confectionery, bean confectionery, dessert confectionery, and other confectionery.
  • Examples of the gel-like food include foods that utilize the thermal coagulation property of proteins (pudding, chawanmushi, etc.), and jelly-like foods in which a mixed solution containing an aqueous raw material is made into a jelly by a gelling agent.
  • Examples of the jelly-like food include jelly-like foods such as fruit flavor, coffee flavor, milk flavor, green tea flavor, and almond jelly flavor, jelly-like sports beverage, jelly-like oral rehydration solution, and nutritional supplement jelly.
  • Beverages include, for example, carbonated beverages, natural fruit juices, fruit juice beverages, refreshing beverages containing fruit juice, fruit meat beverages, fruit beverages containing fruit grains, vegetable beverages, soy milk, soy milk beverages, coffee beverages, tea beverages, powdered beverages, concentrated beverages, sports. Beverages, oral rehydration solutions, nutritional beverages, alcoholic beverages, other favorite beverages and the like can be mentioned. Examples of commercially available foods other than the above include baby foods, sprinkles, and ochazuke paste.
  • the food and drink and the food and drink composition can be produced by a method known to those skilled in the art, and may be produced by adding a lactic acid compound and fructose to the known food and drink, or in the raw material of the food and drink. It can also be mixed to produce new foods and drinks and food and drink compositions.
  • lactic acid compounds and fructose in addition to the steps of adding and mixing lactic acid compounds and fructose, molding steps, sterilization steps, fermentation steps, baking steps, drying steps, cooling steps, granulation steps, packaging steps, etc. Can be combined as appropriate.
  • Preferred forms of food and drink include sports drinks taken during exercise, before or after exercise, drinks such as oral rehydration solutions, and powdered drinks prepared and used as drinks.
  • various components usually contained in beverages such as sweeteners other than fructose, acidulants, vitamins such as vitamin A, vitamin B, and vitamin E, and antioxidants are included in beverages.
  • Preservatives such as sodium benzoate, thickeners, emulsifiers, sodium, calcium, magnesium, potassium, zinc, iron, manganese, copper and other minerals, sodium glutamate, lysine hydrochloride, carnitine citrulin, arginine, ornithine, etc.
  • Amino acids and their salts herbal fragrances, apple, grape, grapefruit, pineapple, peach, lemon, plum, orange and other fruit juices and their concentrated juices, royal jelly, galana extract, caffeine, garlic extract, maca extract, raw medicine, A seaweed extract or the like can be arbitrarily added as long as the effect of the present invention is not impaired.
  • sweeteners other than fructose include sugars such as sucrose, glucose, granulated sugar, lactose, and maltose, and low-sweetness sweeteners such as xylitol and D-sorbitol.
  • the acidulant include citrates such as trisodium citrate, anhydrous citric acid, adipic acid, gluconic acid, succinic acid, tartrate acid, fumaric acid, malic acid, phytic acid, ascorbic acid and salts thereof.
  • the pH of the beverage at a temperature of 20 ° C. is preferably 3.5 to 4.6, more preferably 3.7 to 4.2, and even more preferably 3.8 to 4.1. This makes it possible to maintain a good aftertaste.
  • the pH can be adjusted, for example, by adjusting the type and amount of the lactic acid compound, or by using a pH adjusting agent.
  • Beverages can be obtained, for example, by uniformly mixing lactic acid compounds, fructose, and other components added as needed with water according to a conventional method.
  • the beverage may be a packaged beverage that has been sterilized by heating and packed in a container.
  • Examples of the packaged beverage include a packaged beverage having a total volume of 100 mL or more and 500 mL or less.
  • the timing of blending each component is not limited to before the sterilization treatment, and a specific component, for example, an aroma component having a relatively high volatility may be blended after the sterilization treatment.
  • the container examples include a sealed container made of a single substance such as glass, paper, plastic (polyethylene terephthalate, etc.), aluminum, and steel, or a composite material or laminated material thereof.
  • the type of container is not particularly limited, and examples thereof include PET bottles, aluminum cans, steel cans, paper packs, chilled cups, and bottles. From the viewpoint of handleability, distribution, portability, etc., the container is preferably a paper pack or a PET bottle.
  • Foods and drinks and food and drink compositions can be provided and sold as foods and drinks and food and drink compositions labeled with health uses such as activation of muscle activity, reduction of muscle fatigue, anti-fatigue, and improvement of endurance. Is. Such indications are not particularly limited, but for example, "improve exercise performance”, “reduce the feeling of fatigue caused by exercise”, “prevent muscle cramps during and after exercise, and leg cramps (so-called” fishing "). "Reduce and improve”, “Reduce the feeling of fatigue caused by work and study”, “Maintain / improve memory”, “Maintain / improve attention”, “Maintain / improve concentration”, etc. Be done.
  • the act of "displaying” includes all actions for informing the consumer of the above-mentioned use, and if the expression is such that the above-mentioned use can be recalled or inferred, the purpose of the display, the content of the display, and the display are used. Regardless of the object, medium, etc., all fall under the "display" act of the present invention.
  • “Indication” also includes labeling as health foods, functional foods, enteral nutrition foods, special purpose foods, health functional foods, specified health foods, nutritional functional foods, functionally labeled foods, non-medicinal products, etc. Can be mentioned. Among these, in particular, labeling approved by the Consumer Affairs Agency, for example, a system related to foods for specified health use, nutritionally functional foods, or foods with functional claims, or labeling approved by a system similar to these can be mentioned. Specifically, labeling as a food for specified health use, labeling as a food for specified health use with conditions, labeling as a food with functional claims, labeling to the effect that it affects the structure and function of the body, labeling for reducing disease risk, science The display of functionality based on the scientific basis can be mentioned.
  • the agent according to the present invention is a blood lactate concentration increasing agent, an anti-fatigue agent, an endurance improving agent, a muscle activity activator, or a muscle fatigue reducing agent.
  • the blood lactic acid concentration increasing agent (hereinafter, also simply referred to as “blood lactic acid concentration increasing agent”) according to the present invention contains a lactic acid compound and fructose as active ingredients.
  • a lactic acid compound and fructose as active ingredients.
  • including as an active ingredient means that it is contained in an effective amount that can increase the lactic acid concentration in blood.
  • the lactic acid compound and fructose the above description of the lactic acid compound and fructose contained in the food and drink is applied.
  • Increasing the blood lactate concentration means that the blood lactate concentration of the administered individual can be increased at a specific time after administration, or the value can be increased at a certain period after administration. It means having at least one action of being able to maintain.
  • the blood lactate concentration increasing agent may further contain other components known to increase the blood lactate concentration.
  • Lactic acid in blood is known to act effectively on activating muscle activity and reducing muscle fatigue. Therefore, the blood lactate concentration increasing agent can be used both as a muscle activity activator that promotes activation of muscle activity in exercise such as sports and training, and as a muscle fatigue reducing agent that reduces muscle fatigue due to exercise.
  • the anti-fatigue agent according to the present invention contains a lactic acid compound and fructose as active ingredients.
  • an active ingredient means that it is contained in an effective amount capable of exerting an anti-fatigue effect.
  • the lactic acid compound and fructose the above description of the lactic acid compound and fructose contained in the food and drink is applied.
  • the anti-fatigue effect the above description of the anti-fatigue effect in foods and drinks is applied.
  • the anti-fatigue agent according to the present invention may be the blood lactate concentration increasing agent itself according to the present invention, or may further contain a blood lactate concentration increasing agent and other components, and may be used as other components. Includes other ingredients known to have anti-fatigue activity.
  • the endurance improving agent according to the present invention contains a lactic acid compound and fructose as active ingredients.
  • including as an active ingredient means that it is contained in an effective amount capable of exerting an endurance improving effect.
  • the lactic acid compound and fructose the above description of the lactic acid compound and fructose contained in the food and drink is applied.
  • the endurance improving action the above-mentioned explanation of the endurance improving action in foods and drinks is applied.
  • the endurance improving agent according to the present invention may be the blood lactate concentration increasing agent itself according to the present invention, may further contain a blood lactate concentration increasing agent and other components, and may be another component. Examples include other components known to have an endurance-enhancing effect.
  • the muscle activity activator according to the present invention (hereinafter, also simply referred to as “muscle activity activator”) is the blood lactate concentration increasing agent, the anti-fatigue agent, or the endurance improving agent itself according to the present invention. It may further contain a blood lactate concentration increasing agent and other components, and other components include other components known to activate muscle activity.
  • the muscle fatigue reducing agent according to the present invention may be the blood lactate concentration increasing agent or the anti-fatigue agent itself according to the present invention, and may be the blood lactate concentration. It may further contain an elevating agent and other components, and other components include other components known to suppress muscle fatigue.
  • Examples of the route of administration of the blood lactic acid concentration increasing agent, anti-fatigue agent, endurance improving agent, muscle activity activator, and muscle fatigue reducing agent include parenteral administration such as oral administration and enteral administration.
  • Examples of the dosage form of the blood lactic acid concentration increasing agent include sprays, capsules, tablets, granules, syrups, emulsions, suppositories, injections, ointments, tapes and the like.
  • the doses of lactic acid compounds and fructose which are the active ingredients of blood lactate concentration-increasing agents, anti-fatigue agents, endurance enhancers, muscle activity activators, and muscle fatigue-reducing agents, are determined by the dosage form, symptoms to be administered, and age.
  • the dose of lactic acid compound should be 3 g or more and 75 g or less and lactic acid should be 7 g or more and 150 g or less per adult. It is preferable to have.
  • Mammals are exemplified as the administration target. Examples of mammals include humans, cows, sheep, goats, pigs, dogs, cats, horses and the like.
  • additives such as excipients, binders, disintegrants, lubricants, stabilizers, flavoring agents, diluents, and solvents for injections can be used.
  • the content of each of the lactic acid compound and fructose in the formulation is preferably 1 to 50% by mass, particularly preferably 3 to 30% by mass, although it depends on the dosage form.
  • excipients include cellulose derivatives such as crystalline cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxymethyl cellulose, and carboxymethyl cellulose calcium; gum arabic; dextran; purulan; light anhydrous silicic acid, synthetic aluminum silicate, magnesium aluminometasilicate. And the like; silicate derivatives such as calcium phosphate; carbonate derivatives such as calcium carbonate; sulfate derivatives such as calcium sulfate.
  • binder examples include gelatin; polyvinylpyrrolidone; tunagor and the like in addition to the above-mentioned excipients.
  • disintegrant examples include, in addition to the above-mentioned excipients, chemically modified starch or cellulose derivatives such as croscarmellose sodium, carboxymethyl starch sodium, and crosslinked polyvinylpyrrolidone.
  • lubricant examples include talc; stearic acid; stearic acid metal salts such as calcium stearate and magnesium stearate; colloidal silica; waxes such as bee gum and gay wax; boric acid; glycol; carboxylic acids such as fumaric acid and adipic acid.
  • Carboxylic acid sodium salt such as sodium benzoate; Sulfate salt such as sodium sulfate; Leucine; Lauryl sulfate such as sodium lauryl sulfate and magnesium lauryl sulfate; Silic acid such as anhydrous silicic acid and silicic acid hydrate; starch derivative etc. Can be mentioned.
  • the stabilizer examples include paraoxybenzoic acid esters such as methylparaben and propylparaben; alcohols such as chlorobutanol, benzyl alcohol and phenylethyl alcohol; benzalkonium chloride; acetic anhydride; sorbic acid and the like.
  • Examples of the flavoring agent include sweeteners, acidulants, and fragrances.
  • Examples of the solvent for injection include water, ethanol, glycerin and the like.
  • the composition according to the present invention is a composition for increasing blood lactate concentration, a composition for anti-fatigue, a composition for improving endurance, a composition for activating muscle activity, or a composition for reducing muscle fatigue.
  • Lactic acid compounds and fructose are used in the production of the composition according to the present invention.
  • the lactic acid compound and fructose the above description of the lactic acid compound and fructose contained in the food and drink is applied.
  • the composition for increasing the blood lactate concentration according to the present invention contains the above-mentioned blood lactate concentration increasing agent, and may be the above-mentioned blood lactate concentration increasing agent itself.
  • the anti-fatigue composition according to the present invention contains the above-mentioned anti-fatigue agent, and may be the above-mentioned anti-fatigue agent itself.
  • the composition for improving endurance according to the present invention contains the above-mentioned endurance improving agent, and may be the above-mentioned endurance improving agent itself.
  • the composition for activating muscle activity according to the present invention contains the above-mentioned muscle activity activator, and may be the above-mentioned muscle activity activator itself.
  • the composition for reducing muscle fatigue according to the present invention contains the above-mentioned muscle fatigue reducing agent, and may be the above-mentioned muscle fatigue reducing agent itself.
  • Examples of the form of the composition according to the present invention include a pharmaceutical composition, a food and drink composition, and a feed composition.
  • a pharmaceutical composition it is preferable to prepare the pharmaceutical composition by adding any additive such as a pharmaceutically acceptable excipient together with a lactic acid compound and fructose to formulate the desired dosage form.
  • a food or drink composition the above description of the form of the food or drink composition is applied.
  • Examples of the feed composition include pet food, livestock feed, fish feed and the like.
  • the feed composition is prepared by mixing a lactic acid compound and fructose with a general feed or its raw materials such as grains, lees, brans, fish meal, bone meal, fats and oils, skim milk powder, whey, mineral feed, and yeasts. It can be manufactured by doing so.
  • the produced feed composition can be orally administered to general mammals, livestock, fish farms, pet animals and the like.
  • the method for increasing the blood lactic acid concentration, the anti-fatigue method, the endurance improving method, the method for activating muscle activity, and the method for reducing muscle fatigue according to the present invention are to administer a lactic acid compound and fructose to a mammal. Including the process of When the lactic acid compound and fructose are administered and the lactic acid compound and fructose are present in the body at the same timing, the concentration of lactic acid in the blood can be increased, the anti-fatigue effect can be exhibited, and the endurance is enhanced.
  • Lactic acid compounds and fructose were added to water to prepare beverages 1 to 7 having a total amount of 200 ml containing the amounts of lactic acid (total amount of lactic acid compounds in terms of lactic acid) and fructose shown in Table 1.
  • lactic acid powder manufactured by Corbion Japan Co., Ltd.
  • calcium lactate powder manufactured by Corbion Japan Co., Ltd.
  • sodium lactate solution manufactured by Corbion Japan Co., Ltd.
  • potassium lactate solution co.
  • lactic acid was the value shown in Table 1 and the pH of the beverage was 3.7 or more and 4.0 or less.
  • the total amount in terms of lactic acid may be simply referred to as the content of "lactic acid” below.
  • Pure fructose manufactured by Kato Chemical Co., Ltd. was used as a raw material for fructose.
  • Test Examples 1 to 7 In Test Examples 1 to 7, the subjects were allowed to ingest the beverages 1 to 7, respectively, and the effect of oral ingestion of the beverage according to the present invention on the blood lactate concentration was confirmed. Three healthy men and women (ages 30 to 60 years) were used as subjects, and the same three subjects were used in Test Examples 1 to 7. Test Examples 1 to 7 were performed on different days.
  • Test Example 1 In a measuring room with a temperature of 24 ° C. and a relative humidity of 50%, the subject received the measurement while sitting. After fasting for 4 hours, the subject collected blood from the fingertips and measured the blood lactate concentration with a measuring device manufactured by ARKRAY (product name: Lactate Pro 2 LT-1730). After that, the subject ingested the beverage 1. Then, the blood lactate concentration was measured every 10 minutes after ingestion of the beverage 1 until 60 minutes had passed by the same method as described above. The subject was fasted until 60 minutes after ingesting the beverage 1. Based on the measurement results, the time (in 10-minute increments) at which the blood lactate concentration was maintained at 2 mol / L or higher was calculated for each subject, and the average time of the three subjects was calculated. The results are shown in Table 2.
  • Test Examples 2 to 7 In Test Examples 2 to 7, the same tests as in Test Example 1 were carried out using beverages 2 to 7, respectively, instead of the beverage 1 used in Test Example 1. Then, the average time of the three subjects was calculated in the same manner as in Test Example 1. The results are shown in Table 2.
  • Test Examples 8 to 10 In Test Examples 8 to 10, the subjects were ingested the beverages 1, 3 and 6, respectively, and then exercise was applied, and the effect of oral administration of the beverage according to the present invention on the blood lactic acid concentration was confirmed. The subjects were three healthy men and women (ages 30 to 60 years). In Test Examples 8 to 10, the same three subjects were used. Test Examples 8 to 10 were performed on different days.
  • Test Example 8 The measurement was performed in a measurement room having a temperature of 24 ° C. and a relative humidity of 50%, and the subject received the measurement while sitting. After fasting for 2 hours or more, the subject collected blood from the fingertips and measured the blood lactate concentration with a measuring device manufactured by ARKRAY (product name: Lactate Pro 2 LT-1730). The subject was then ingested Beverage 1 and subjected to low intensity bicycle ergometer exercise for 60 minutes. Then, the blood lactate concentration was measured every 10 minutes after ingestion of the beverage 1 until 60 minutes had passed by the same method as described above. Based on the measurement results, the time (in 10-minute increments) at which the blood lactate concentration was maintained at 4 mmol / L or higher was calculated for each subject, and the average time of the three subjects was calculated. The results are shown in Table 3.
  • Test Examples 9 and 10 In Test Examples 9 and 10, the same test as in Test Example 8 was performed using beverages 3 and 6, respectively, instead of the beverage 1 used in Test Example 8. Then, the average time of the three subjects was calculated in the same manner as in Test Example 8. The results are shown in Table 3.
  • Test Example B In Test Example B, the subjects were allowed to ingest the three types of beverages B1, B2, and B3 shown in Table 4, respectively, to obtain an anti-fatigue effect against fatigue caused by oral ingestion of the beverage according to the present invention and an effect of improving endurance in exercise. evaluated. Powdered water candy (M-SPD-M manufactured by Showa Sangyo Co., Ltd.) was used to prepare beverage B2, and lactic acid powder (fermented by Corbion Japan Co., Ltd.) was used as a raw material for lactic acid compounds to prepare beverage B3.
  • Powdered water candy M-SPD-M manufactured by Showa Sangyo Co., Ltd.
  • lactic acid powder Fermented by Corbion Japan Co., Ltd.
  • Lactate powder 60 calcium lactate powder (fermented calcium lactate manufactured by Corbion Japan Co., Ltd.), sodium lactate solution (60% fermented sodium lactate manufactured by Corbion Japan Co., Ltd.), potassium lactate solution (Corbion Japan Co., Ltd.) ), Puresal (registered trademark) HiPure P Plus) was used, and pure lactate (manufactured by Kato Chemical Co., Ltd.) was used as a raw material for lactate.
  • Test Example C In Test Example C, the subjects were allowed to ingest the three types of beverages C1, C2, and C3 shown in Table 5, respectively, and the anti-fatigue effect against fatigue due to mental activity due to oral ingestion of the beverage according to the present invention was evaluated. Lactic acid powder, calcium lactate, sodium lactate, and potassium lactate (all manufactured by Corbion Japan Co., Ltd.) are used as raw materials for lactic acid compounds, and pure fructose (Kato Kagaku (Kato Kagaku)) is used as a raw material for fructose to prepare beverages C2 and C3. Co., Ltd.) was used.
  • Table 5 shows the average value of the change in the measured value after ingestion from the measured value before ingestion of 7 subjects.
  • VAS Visual Analog Scale

Abstract

Provided is a novel food and drink which can continuously increase the lactic acid concentration in the blood. This food and drink contains a lactic acid compound and fructose, wherein the content of the lactic acid compound is 3-75 g in terms of lactic acid, and the content of the fructose is 7-150 g.

Description

飲食品、抗疲労剤、および持久力向上剤Food and drink, anti-fatigue agents, and endurance improvers
 本発明は、抗疲労または持久力向上に有用な飲食品に関するものであり、抗疲労剤および持久力向上剤にも関する。 The present invention relates to foods and drinks useful for anti-fatigue or endurance improvement, and also relates to anti-fatigue agents and endurance improving agents.
 運動中、または運動の前後で摂取する飲食品として、筋活動の活性化および筋疲労の低減を補助する機能を有する有効成分を含むものが種々知られている。例えば、特許文献1には、ヘスペリジン類と乳脂肪球皮膜を有効成分とする運動に伴う筋疲労回復用食品組成物が開示されている。 As foods and drinks to be ingested during or before and after exercise, various foods and drinks containing an active ingredient having a function of assisting activation of muscle activity and reduction of muscle fatigue are known. For example, Patent Document 1 discloses a food composition for recovering muscle fatigue associated with exercise, which contains hesperidins and a milk fat globules as active ingredients.
 近年、血中の乳酸がもたらす作用が注目されている。非特許文献1では、速筋で産生された乳酸が遅筋に運ばれて酸化的条件でのATP産生に利用されることが開示されている。非特許文献2では、高強度トレーニングにより血中の乳酸濃度が上昇し、ミトコンドリア適応、すなわち代謝の改善が促進されることが報告されている。非特許文献3では、血中の乳酸が筋肥大をもたらすことが報告されている。 In recent years, attention has been paid to the action of lactic acid in blood. Non-Patent Document 1 discloses that lactic acid produced in fast muscle is carried to slow muscle and used for ATP production under oxidative conditions. Non-Patent Document 2 reports that high-intensity training increases blood lactate concentration and promotes mitochondrial adaptation, that is, improvement of metabolism. Non-Patent Document 3 reports that lactic acid in blood causes muscle hypertrophy.
 血中の乳酸上昇によりもたらされる、非特許文献1~3に記載されているような上述の作用は、筋活動の活性化および筋疲労の低減に有用である。なお、非特許文献4には、大量に果糖を摂取すると、血中乳酸濃度が上昇することが開示されている。 The above-mentioned actions as described in Non-Patent Documents 1 to 3 brought about by an increase in lactic acid in blood are useful for activating muscle activity and reducing muscle fatigue. In addition, Non-Patent Document 4 discloses that when a large amount of fructose is ingested, the blood lactate concentration increases.
特開2019-182803号公報Japanese Unexamined Patent Publication No. 2019-182803
 本発明は、血中の乳酸濃度を持続的に上昇させることができる新たな飲食品、抗疲労剤、および持久力向上剤を提供することを目的とする。 An object of the present invention is to provide a new food or drink, an anti-fatigue agent, and an endurance improving agent capable of continuously increasing the blood lactic acid concentration.
 本発明は、以下に例示する[1]~[14]に関する。
 [1] 乳酸化合物および果糖を含み、前記乳酸化合物の含有量が乳酸換算で3g以上75g以下であり、前記果糖の含有量が7g以上150g以下である、飲食品。
The present invention relates to [1] to [14] exemplified below.
[1] A food or drink containing a lactic acid compound and fructose, wherein the content of the lactic acid compound is 3 g or more and 75 g or less in terms of lactic acid, and the content of the fructose is 7 g or more and 150 g or less.
 [2] 乳酸化合物は、乳酸、乳酸カリウム、乳酸カルシウム、乳酸鉄、および乳酸ナトリウムからなる群より選択される1種以上である、[1]に記載の飲食品。 [2] The food or drink according to [1], wherein the lactic acid compound is at least one selected from the group consisting of lactic acid, potassium lactate, calcium lactate, iron lactate, and sodium lactate.
 [3] 飲料、または飲料に調製して用いられる粉末飲料である、[1]または[2]に記載の飲食品。 [3] The food or drink according to [1] or [2], which is a beverage or a powdered beverage prepared and used as a beverage.
 [4] 総量が100mL以上500mL以下の容器詰飲料である、[3]に記載の飲食品。 [4] The food or drink according to [3], which is a packaged beverage having a total volume of 100 mL or more and 500 mL or less.
 [5] 乳酸化合物および果糖を含み、
 前記乳酸化合物の含有量が乳酸換算で0.6質量%以上30質量%以下であり、
 前記果糖の含有量が1.4質量%以上60質量%以下である、飲食品組成物。
[5] Contains lactic acid compounds and fructose,
The content of the lactic acid compound is 0.6% by mass or more and 30% by mass or less in terms of lactic acid.
A food or drink composition having a fructose content of 1.4% by mass or more and 60% by mass or less.
 [6] 乳酸化合物および果糖を有効成分として含む、血中乳酸濃度上昇剤。
 [7] 乳酸化合物および果糖を有効成分として含む、抗疲労剤または持久力向上剤である剤。
[6] An agent for increasing blood lactic acid concentration, which contains a lactic acid compound and fructose as active ingredients.
[7] An agent which is an anti-fatigue agent or an endurance improving agent containing a lactic acid compound and fructose as active ingredients.
 [8] 筋活動活性化剤または筋疲労低減剤である、[7]に記載の剤。
 [9] 肉体疲労の抗疲労剤である、[7]に記載の剤。
[8] The agent according to [7], which is a muscle activity activator or a muscle fatigue reducing agent.
[9] The agent according to [7], which is an anti-fatigue agent for physical fatigue.
 [10] 精神疲労の抗疲労剤である、[7]に記載の剤。
 [11] 成人1人1回当たり、前記乳酸化合物が乳酸換算で3g以上75g以下、前記果糖が7g以上150g以下の投与量となるように用いられる、[7]~[10]のいずれか1項に記載の剤。
[10] The agent according to [7], which is an anti-fatigue agent for mental fatigue.
[11] Any one of [7] to [10], wherein the lactic acid compound is used in a dose of 3 g or more and 75 g or less and fructose is used in a dose of 7 g or more and 150 g or less per adult. The agent described in the section.
 [12] 抗疲労用組成物、または持久力向上用組成物の製造における、乳酸化合物および果糖の使用。 [12] Use of lactic acid compounds and fructose in the production of anti-fatigue compositions or endurance-enhancing compositions.
 [13] 乳酸化合物および果糖を哺乳動物に投与する工程を含む、抗疲労方法。
 [14] 乳酸化合物および果糖を哺乳動物に投与する工程を含む、持久力向上方法。
[13] An anti-fatigue method comprising a step of administering a lactic acid compound and fructose to a mammal.
[14] A method for improving endurance, which comprises a step of administering a lactic acid compound and fructose to a mammal.
 本発明によれば、血中の乳酸濃度を持続的に上昇させることができる新たな飲食品、抗疲労剤、持久力向上剤、筋活動向上剤、および筋疲労回復剤を提供することができる。 According to the present invention, it is possible to provide a new food or drink, an anti-fatigue agent, an endurance improving agent, a muscle activity improving agent, and a muscle fatigue recovering agent capable of continuously increasing the blood lactic acid concentration. ..
 <飲食品>
 本発明に係る飲食品(以下、単に「飲食品」ともいう。)は、乳酸化合物および果糖を含み、乳酸化合物の含有量が乳酸換算で3g以上75g以下であり、果糖の含有量が7g以上150g以下である。飲食品は、乳酸化合物の含有量が乳酸換算で5g以上50g以下であることが好ましく、果糖の含有量が20g以上100g以下であることが好ましい。飲食品は、乳酸化合物の含有量が乳酸換算で15g以上20g以下であることがより好ましく、果糖の含有量が30g以上50g以下であることがより好ましい。本発明に係る飲食品によると、摂取した個体の血中乳酸濃度を持続的に上昇させることができる。
<Food and drink>
The food or drink according to the present invention (hereinafter, also simply referred to as “food or drink”) contains a lactic acid compound and fructose, the content of the lactic acid compound is 3 g or more and 75 g or less in terms of lactic acid, and the content of fructose is 7 g or more. It is 150 g or less. The food and drink preferably has a lactic acid compound content of 5 g or more and 50 g or less, and a fructose content of 20 g or more and 100 g or less. The content of the lactic acid compound in the food and drink is more preferably 15 g or more and 20 g or less in terms of lactic acid, and the fructose content is more preferably 30 g or more and 50 g or less. According to the food and drink according to the present invention, the blood lactic acid concentration of the ingested individual can be continuously increased.
 飲食品は、1食当たりに摂取されるものであってもよく、1回で摂取されるものであってもよく、複数回で摂取されるものであってもよい。複数回で摂取される場合、血中乳酸濃度をより持続的に上昇させる観点から、乳酸化合物については乳酸換算で少なくとも3gおよび果糖については少なくとも7gが、同じタイミングで体内に摂取されることが好ましい。本明細書でいう同じタイミングとしては、例えば10分以内が好ましく、5分以内がより好ましい。飲食品は個包装で提供されるものであってもよい。 The food and drink may be ingested per meal, may be ingested once, or may be ingested in multiple times. When ingested multiple times, it is preferable that at least 3 g of lactic acid compound and at least 7 g of fructose are ingested into the body at the same timing from the viewpoint of increasing the blood lactate concentration more continuously. .. As the same timing as used herein, for example, within 10 minutes is preferable, and within 5 minutes is more preferable. Food and drink may be provided in individual packages.
 本発明に係る飲食品組成物(以下、単に「飲食品組成物」ともいう。)は、乳酸化合物の含有量が乳酸換算で0.6質量%以上30質量%以下、果糖の含有量が1.4質量%以上60質量%以下である。果糖の含有量は好ましくは30質量%以下であり、より好ましくは15質量%以下である。本発明に係る飲食品組成物によると、摂取した個体の血中乳酸濃度を持続的に上昇させることができる。飲食品組成物は、例えば、これを用いて本発明に係る上述の飲食品を調製することができる。 The food or drink composition according to the present invention (hereinafter, also simply referred to as “food and drink composition”) has a lactic acid compound content of 0.6% by mass or more and 30% by mass or less in terms of lactic acid, and a fructose content of 1. It is 4% by mass or more and 60% by mass or less. The fructose content is preferably 30% by mass or less, more preferably 15% by mass or less. According to the food and drink composition according to the present invention, the blood lactic acid concentration of the ingested individual can be continuously increased. The food and drink composition can be used, for example, to prepare the above-mentioned food and drink according to the present invention.
 飲食品および飲食品組成物に含まれる乳酸化合物は、好ましくは、乳酸、乳酸カリウム、乳酸カルシウム、乳酸鉄、および乳酸ナトリウムからなる群より選択される1種以上である。飲食品および飲食品組成物に含まれる乳酸化合物は、乳酸、乳酸塩、またはこれらを含む材料として添加されて含まれるものであってよい。 The lactic acid compound contained in the food or drink and the food or drink composition is preferably one or more selected from the group consisting of lactic acid, potassium lactate, calcium lactate, iron lactate, and sodium lactate. The lactic acid compound contained in the food or drink and the food or drink composition may be lactic acid, lactate, or one added and contained as a material containing these.
 飲食品および飲食品組成物に含まれる果糖は、果糖、または果糖を含む材料として添加されて含まれるものであってよい。果糖を含む材料としては、例えば、高果糖液糖や果糖ブドウ糖液糖等の異性化糖、果汁等が挙げられる。 The fructose contained in the food and drink and the food and drink composition may be fructose or one added and contained as a material containing fructose. Examples of the material containing fructose include high fructose syrup, isomerized sugar such as fructose-glucose syrup, and fruit juice.
 本発明に係る飲食品および飲食品組成物は、摂取した個体の血中の乳酸濃度を持続的に上昇させることができる。摂取した個体の血中の乳酸濃度を持続的に上昇させるとは、摂取しない場合と比較して、摂取した個体の血中の乳酸濃度を、摂取後、ある特定の時間における値を高くすることができること、または摂取後のある一定の時間において高い値に維持することができること、の少なくとも一つの作用を有することを意味する。したがって、本発明に係る飲食品および飲食品組成物は、乳酸濃度上昇剤としても用いることができる。本発明に係る飲食品および飲食品組成物によると、摂取した個体の血中乳酸濃度の摂取後の値を、安静時には、例えば2mmol/L以上の値を達成する、または例えば2mmol/L以上の値を維持する時間を長くすることができ、運動を伴う場合には、例えば4mmol/L以上の値を達成する、または例えば4mmol/L以上の値を維持する時間を長くすることができる、との効果を期待することができる。 The food and drink and the food and drink composition according to the present invention can continuously increase the blood lactic acid concentration of the ingested individual. To continuously increase the blood lactate concentration of an ingested individual means to increase the blood lactate concentration of the ingested individual at a specific time after ingestion as compared with the case of not ingesting. It means that it has at least one effect of being able to, or being able to maintain a high value for a certain period of time after ingestion. Therefore, the food and drink and the food and drink composition according to the present invention can also be used as a lactic acid concentration increasing agent. According to the food and drink and the food and drink composition according to the present invention, the blood lactic acid concentration of the ingested individual achieves a value of, for example, 2 mmol / L or more at rest, or, for example, 2 mmol / L or more. The time to maintain the value can be lengthened, and in the case of exercise, for example, a value of 4 mmol / L or more can be achieved, or the time to maintain a value of, for example, 4 mmol / L or more can be lengthened. The effect of can be expected.
 血中の乳酸は、筋活動の活性化および筋疲労の軽減に有効に作用することが知られている。したがって、本発明に係る飲食品および飲食品組成物は、スポーツ、トレーニング等の運動における筋活動の活性化を促す筋活動活性化剤としても、運動による筋疲労を軽減させる筋疲労軽減剤としても用いることができる。 Lactic acid in blood is known to act effectively on activating muscle activity and reducing muscle fatigue. Therefore, the food and drink and the food and drink composition according to the present invention can be used both as a muscle activity activator that promotes activation of muscle activity in exercise such as sports and training, and as a muscle fatigue reducing agent that reduces muscle fatigue due to exercise. Can be used.
 本明細書において、ヒトの「運動」とは、健康のため、体を鍛えるため、楽しみのために計画的・意図的に実施するスポーツ、ウォーキング、ジョギング、有酸素運動、水泳、サイクリング等の筋肉を使う活動である。また、本明細書において「運動」には、労働、家事等の日常の生活における身体活動も含む。筋活動の活性化により、運動の量、運動の時間、運動の質を向上させることができる。すなわち、筋活動が活性化されると、疲労のわりに運動の時間が長くなったり、運動により移動距離が増加したり、運動中の速度が増加したり、運動における体の動きやキレが増したりする。筋疲労が軽減されると、運動をしても疲労の程度が少なくなったり、運動により疲労してもその回復が早かったりする。 In the present specification, human "exercise" means muscles such as sports, walking, jogging, aerobic exercise, swimming, cycling, etc., which are intentionally and intentionally carried out for health, physical fitness, and enjoyment. It is an activity that uses. Further, in the present specification, "exercise" includes physical activities in daily life such as labor and housework. Activation of muscle activity can improve the amount of exercise, the duration of exercise, and the quality of exercise. That is, when muscle activity is activated, the time of exercise becomes longer instead of fatigue, the distance traveled by exercise increases, the speed during exercise increases, and the movement and sharpness of the body during exercise increase. do. When muscle fatigue is reduced, the degree of fatigue is reduced even if exercise is performed, and recovery is quick even if fatigue is caused by exercise.
 飲食品および飲食品組成物は、筋活動の活性化および筋疲労の軽減効果を有することから、運動の前、運動の後、または運動中に摂取されることが好ましい。 Foods and drinks and food and drink compositions are preferably taken before, after, or during exercise because they have the effect of activating muscle activity and reducing muscle fatigue.
 本発明に係る飲食品および飲食品組成物は、抗疲労作用および持久力向上作用を有し、ヒトがこれを飲食服用すると抗疲労作用および/または持久力向上作用を発揮する。 The food and drink and the food and drink composition according to the present invention have an anti-fatigue effect and an endurance-enhancing effect, and when a human takes them, they exhibit an anti-fatigue effect and / or an endurance-improving effect.
 「疲労」は、運動や精神的活動をした結果、運動や精神的活動の機能が低下する現象をいい、肉体疲労と精神疲労に大きく分類される。本発明に係る抗疲労作用は、肉体疲労に対する抗疲労作用であってもよく、精神疲労に対する抗疲労作用であってもよい。本明細書において、ヒトの「運動」とは上述の通りである。本明細書において、ヒトの「精神的活動」とは、ヒトの論理的理解力を伴う精神的活動のことをいう。ヒトの精神的活動の具体的な内容としては、思考作業、計算作業、コンピュータ作業、スマートフォンの操作等が挙げられる。ヒトの精神的活動としては、仕事、勉強等が挙げられる。また、上記のヒトの精神的活動に伴う疲労とは、個人差もあるが、例えば、パソコン作業について1~2時間継続した後の状態をいう。 "Fatigue" refers to a phenomenon in which the function of exercise and mental activity declines as a result of exercise and mental activity, and is broadly classified into physical fatigue and mental fatigue. The anti-fatigue action according to the present invention may be an anti-fatigue action against physical fatigue or an anti-fatigue action against mental fatigue. As used herein, human "exercise" is as described above. As used herein, the term "mental activity" in humans refers to mental activity that accompanies human logical comprehension. Specific contents of human mental activities include thinking work, calculation work, computer work, operation of smartphones, and the like. Examples of human mental activities include work and study. The fatigue associated with the above-mentioned mental activity of a human is, for example, a state after one to two hours of continuous work on a personal computer, although there are individual differences.
 「抗疲労作用」とは、本発明に係る飲食品または飲食品組成物を飲食服用することにより、そのような「疲労」状態を軽減させる作用および「疲労」状態からの回復を促進する作用、あるいは「疲労」を予防し、疲れにくくする作用などをいう。 The "anti-fatigue action" is an action of reducing such a "fatigue" state and an action of promoting recovery from the "fatigue" state by eating and drinking the food or drink or the food or drink composition according to the present invention. Alternatively, it refers to the action of preventing "fatigue" and making it less tiring.
 肉体疲労に対する「抗疲労作用」は、例えば、後述する実施例のように、被験者が運動をした結果、運動機能が低下しないこと、または運動機能が向上すること、を確認することにより評価することができる。肉体的疲労に対する「抗疲労作用」により、例えば、上述のように筋活動を活性化すること、筋疲労を軽減することができる。また、運動のパフォーマンスを向上することができる。 The "anti-fatigue effect" on physical fatigue is evaluated by confirming, for example, that, as a result of the subject's exercise, the motor function does not decrease or the motor function improves, as in the examples described later. Can be done. The "anti-fatigue effect" on physical fatigue can, for example, activate muscle activity and reduce muscle fatigue as described above. It can also improve exercise performance.
 精神的活動に対する「抗疲労作用」は、例えば、後述する実施例のように、クレペリンテストまたはATMT(Advanced Trail Making Test)を実施することにより評価することができる。精神的活動に対する「抗疲労作用」により、例えば、主観的な疲労感を軽減することができる。また、注意力、集中力、記憶力について、低下を抑制することや維持・向上すること、ができる。 The "anti-fatigue effect" on mental activity can be evaluated by, for example, performing a Kraepelin test or ATMT (Advanced Trail Making Test) as in the examples described later. The "anti-fatigue effect" on mental activity can, for example, reduce subjective fatigue. In addition, attention, concentration, and memory can be suppressed, maintained, and improved.
 クレペリンテストは、本来は精神検査を目的として用いられる連続加算作業であり、具体的には、横に並んだ隣り合わせの一桁の数字を順に足していく作業であり、高度な精神的活動の作業に伴う、疲労(精神疲労、大脳疲労、等)発生作業として位置づけることができる。ここでクレペリンテストは、計算能力、コンピュータ作業、連続思考等のモデル系として、定量化のために用いることができる。 The Kraepelin test is a continuous addition work originally used for the purpose of mental examination, specifically, it is a work of adding side-by-side single-digit numbers in order, and is a work of advanced mental activity. It can be positioned as work that causes fatigue (mental fatigue, cerebral fatigue, etc.). Here, the Kraepelin test can be used for quantification as a model system for computational power, computer work, continuous thinking, and the like.
 ATMTは、本来は精神機能検査法として用いられるもので、タッチパネル上に提示されたターゲットとなる数字を順に押していく視覚探索課題で、ターゲット毎の探索反応時間を記録でき、反応毎にターゲットを再配置させたり、あるいは新規に追加発生させたりすることができる。そのため、課題遂行中のワーキングメモリや疲労度を測定することも可能である。 ATMT is originally used as a mental function test method, and is a visual search task in which the target numbers presented on the touch panel are pressed in order. The search reaction time for each target can be recorded, and the target is re-targeted for each reaction. It can be placed or newly generated. Therefore, it is also possible to measure the working memory and the degree of fatigue during task execution.
 「持久力」は、ある一定の運動や精神的活動を継続して行うことができる能力をいい、「持久力向上作用」とは、その継続してできる能力が増強される作用をいう。「持久力向上作用」は、例えば、ある一定の運度や精神的活動の継続時間が延びること、また継続している運動や精神的活動の質が一定以上であること、により確認することができる。 "Endurance" refers to the ability to continue to perform certain exercises and mental activities, and "endurance improving action" refers to the action to enhance the ability to continue. The "endurance improving effect" can be confirmed, for example, by extending a certain degree of luck or duration of mental activity, and by confirming that the quality of continuous exercise or mental activity is above a certain level. can.
 「持久力向上作用」は、例えば、後述する実施例のように、被験者が運動した結果、一定の運動状態を継続して行うことができることを確認することにより評価することができる。運動に対する「持久力向上作用」により、例えば、継続する運動のパフォーマンスを維持・向上することができる。精神的活動に対する「持久力向上作用」により、継続する精神的活動において、注意力、集中力、記憶力の低下を抑制することや維持・向上することができる。 The "endurance improving effect" can be evaluated by confirming that a constant exercise state can be continuously performed as a result of the subject's exercise, for example, as in the examples described later. The "endurance improving effect" on exercise allows, for example, to maintain and improve the performance of continuous exercise. The "endurance improving effect" on mental activity can suppress, maintain, and improve attention, concentration, and memory deterioration in continuous mental activity.
 飲食品および飲食品組成物は、乳酸化合物および果糖のみからなっていてもよく、乳酸化合物および果糖の他に、飲食品に含有させることが許容されるその他の成分を含有していてもよい。飲食品および飲食品組成物は、液状、ゲル状、ペースト状、固体、粉末等の形態を問わず、錠菓、流動食等の形態も含まれる。飲食品および飲食品組成物としては、例えば小麦粉製品、即席食品、農産加工品、水産加工品、畜産加工品、乳・乳製品、油脂類、基礎調味料、複合調味料・食品類、冷凍食品、菓子類、ゲル状食品、飲料、これら以外の市販品等が挙げられる。 The food or drink and the food or drink composition may consist only of a lactic acid compound and fructose, and may contain other components that are permitted to be contained in the food or drink in addition to the lactic acid compound and fructose. The food or drink and the food or drink composition may be in the form of liquid, gel, paste, solid, powder or the like, and may also include tablets, liquid foods and the like. Foods and drinks and food and drink compositions include, for example, flour products, instant foods, processed agricultural products, processed marine products, processed livestock products, milk and dairy products, fats and oils, basic seasonings, complex seasonings and foods, and frozen foods. , Confectionery, gelled foods, beverages, commercial products other than these, and the like.
 小麦粉製品としては、例えばパン、マカロニ、スパゲッティ、めん類、ケーキミックス、から揚げ粉、パン粉等が挙げられる。即席食品類としては、例えば即席めん、カップめん、レトルト・調理食品、調理缶詰め、電子レンジ食品、即席スープ・シチュー、即席みそ汁・吸い物、スープ缶詰め、フリーズ・ドライ食品、その他の即席食品等が挙げられる。農産加工品としては、例えば農産缶詰め、果実缶詰め、ジャム・マーマレード類、漬物、煮豆類、農産乾物類、シリアル(穀物加工品)等が挙げられる。水産加工品としては、例えば水産缶詰め、魚肉ハム・ソーセージ、水産練り製品、水産珍味類、つくだ煮類等が挙げられる。畜産加工品としては、例えば畜産缶詰め・ペースト類、畜肉ハム・ソーセージ等が挙げられる。乳・乳製品としては、例えば発酵乳、加工乳、乳飲料、ヨーグルト類、乳酸菌飲料類、チーズ、アイスクリーム類、調製粉乳類、クリーム、その他の乳製品等が挙げられる。油脂類としては、例えばバター、マーガリン類、植物油等が挙げられる。基礎調味料としては、例えばしょうゆ、みそ、ソース類、トマト加工調味料、みりん類、食酢類等が挙げられる。複合調味料・食品類としては、調理ミックス、カレーの素類、たれ類、ドレッシング類、めんつゆ類、スパイス類、その他の複合調味料等が挙げられる。冷凍食品としては、例えば素材冷凍食品、半調理冷凍食品、調理済冷凍食品等が挙げられる。菓子類としては、例えばキャラメル、キャンディー、チューインガム、チョコレート、クッキー、ビスケット、ケーキ、パイ、スナック、クラッカー、和菓子、米菓子、豆菓子、デザート菓子、その他の菓子等が挙げられる。ゲル状食品としては、タンパク質の熱凝固性を利用した食品(プリン、茶わん蒸し等)、水系原料を含む混合液をゲル化剤によりゼリー状にしたゼリー状食品が挙げられる。ゼリー状食品としては、例えば、フルーツ風味、コーヒー風味、ミルク風味、緑茶風味、杏仁豆腐風味等のゼリー状食品、ゼリー状スポーツ飲料、ゼリー状経口補水液、栄養補助ゼリー等が挙げられる。飲料としては、例えば炭酸飲料、天然果汁、果汁飲料、果汁入り清涼飲料、果肉飲料、果粒入り果実飲料、野菜系飲料、豆乳、豆乳飲料、コーヒー飲料、お茶飲料、粉末飲料、濃縮飲料、スポーツ飲料、経口補水液、栄養飲料、アルコール飲料、その他の嗜好飲料等が挙げられる。上記以外の市販食品としては、例えばベビーフード、ふりかけ、お茶漬けのり等が挙げられる。 Examples of wheat flour products include bread, macaroni, spaghetti, noodles, cake mix, fried chicken flour, bread crumbs and the like. Examples of instant foods include instant noodles, cup noodles, retort / cooked foods, canned foods, microwave foods, instant soups / stews, instant miso soups / soups, canned soups, freeze / dry foods, and other instant foods. .. Examples of processed agricultural products include canned agricultural products, canned fruits, jams and marmalades, pickles, boiled beans, dried agricultural products, cereals (processed grain products) and the like. Examples of processed fishery products include canned fishery products, fish hams and sausages, fish paste products, fishery delicacies, and tsukudani. Examples of processed livestock products include canned livestock and pastes, livestock ham and sausage. Examples of milk and dairy products include fermented milk, processed milk, milk drinks, yogurts, lactic acid bacteria drinks, cheese, ice creams, prepared milk powders, creams, and other dairy products. Examples of fats and oils include butter, margarines, vegetable oils and the like. Examples of the basic seasoning include soy sauce, miso, sauces, processed tomato seasonings, mirin, vinegar and the like. Examples of complex seasonings / foods include cooking mixes, curry ingredients, sauces, dressings, noodle soups, spices, and other complex seasonings. Examples of the frozen food include raw material frozen food, semi-cooked frozen food, and cooked frozen food. Examples of confectionery include caramel, candy, chewing gum, chocolate, cookies, biscuits, cakes, pies, snacks, crackers, Japanese confectionery, rice confectionery, bean confectionery, dessert confectionery, and other confectionery. Examples of the gel-like food include foods that utilize the thermal coagulation property of proteins (pudding, chawanmushi, etc.), and jelly-like foods in which a mixed solution containing an aqueous raw material is made into a jelly by a gelling agent. Examples of the jelly-like food include jelly-like foods such as fruit flavor, coffee flavor, milk flavor, green tea flavor, and almond jelly flavor, jelly-like sports beverage, jelly-like oral rehydration solution, and nutritional supplement jelly. Beverages include, for example, carbonated beverages, natural fruit juices, fruit juice beverages, refreshing beverages containing fruit juice, fruit meat beverages, fruit beverages containing fruit grains, vegetable beverages, soy milk, soy milk beverages, coffee beverages, tea beverages, powdered beverages, concentrated beverages, sports. Beverages, oral rehydration solutions, nutritional beverages, alcoholic beverages, other favorite beverages and the like can be mentioned. Examples of commercially available foods other than the above include baby foods, sprinkles, and ochazuke paste.
 飲食品および飲食品組成物の製造は、当業者に公知の方法で行うことができ、乳酸化合物および果糖を公知の飲食品に添加することによって製造してもよいし、飲食品の原料中に混合して新たな飲食品および飲食品組成物を製造することもできる。飲食品および飲食品組成物の製造は、乳酸化合物および果糖を添加および混合する工程の他に、成形工程、殺菌工程、発酵工程、焼成工程、乾燥工程、冷却工程、造粒工程、包装工程等を適宜組み合わせて行うことができる。 The food and drink and the food and drink composition can be produced by a method known to those skilled in the art, and may be produced by adding a lactic acid compound and fructose to the known food and drink, or in the raw material of the food and drink. It can also be mixed to produce new foods and drinks and food and drink compositions. In the production of foods and drinks and food and drink compositions, in addition to the steps of adding and mixing lactic acid compounds and fructose, molding steps, sterilization steps, fermentation steps, baking steps, drying steps, cooling steps, granulation steps, packaging steps, etc. Can be combined as appropriate.
 飲食品の好ましい形態として、運動時、運動前または運動後に摂取されるスポーツ飲料、経口補水液等の飲料、または飲料に調製して用いられる粉末飲料が挙げられる。 Preferred forms of food and drink include sports drinks taken during exercise, before or after exercise, drinks such as oral rehydration solutions, and powdered drinks prepared and used as drinks.
 飲料には、乳酸化合物および果糖の他に、通常飲料に配合される種々の成分、例えば、果糖以外の甘味料、酸味料、ビタミンA、ビタミンB類、ビタミンE等のビタミン類、酸化防止剤、安息香酸ナトリウム等の保存剤、増粘剤、乳化剤、ナトリウム、カルシウム、マグネシウム、カリウム、亜鉛、鉄、マンガン、銅等のミネラル類、グルタミン酸ナトリウム、リジン塩酸塩、カルニチンシトルリン、アルギニン、オルニチン等のアミノ酸やその塩、ハーブ系等の香料、アップル、グレープ、グレープフルーツ、パイナップル、ピーチ、レモン、梅、オレンジ等の果汁およびそれらの濃縮果汁、ローヤルゼリー、ガラナエキス、カフェイン、ニンニクエキス、マカエキス、生薬、海藻エキス等を本発明の効果を損なわない限度で任意に添加することができる。 In addition to lactic acid compounds and fructose, various components usually contained in beverages, such as sweeteners other than fructose, acidulants, vitamins such as vitamin A, vitamin B, and vitamin E, and antioxidants are included in beverages. , Preservatives such as sodium benzoate, thickeners, emulsifiers, sodium, calcium, magnesium, potassium, zinc, iron, manganese, copper and other minerals, sodium glutamate, lysine hydrochloride, carnitine citrulin, arginine, ornithine, etc. Amino acids and their salts, herbal fragrances, apple, grape, grapefruit, pineapple, peach, lemon, plum, orange and other fruit juices and their concentrated juices, royal jelly, galana extract, caffeine, garlic extract, maca extract, raw medicine, A seaweed extract or the like can be arbitrarily added as long as the effect of the present invention is not impaired.
 果糖以外の甘味料としては、ショ糖、ブドウ糖、グラニュー糖、乳糖、および麦芽糖等の糖類、キシリトール、およびD-ソルビトール等の低甘味度甘味料が挙げられる。酸味料としては、クエン酸三ナトリウムなどのクエン酸塩、無水クエン酸、アジピン酸、グルコン酸、コハク酸、酒石酸、フマル酸、リンゴ酸、フィチン酸、アスコルビン酸またはそれらの塩類等が挙げられる。 Examples of sweeteners other than fructose include sugars such as sucrose, glucose, granulated sugar, lactose, and maltose, and low-sweetness sweeteners such as xylitol and D-sorbitol. Examples of the acidulant include citrates such as trisodium citrate, anhydrous citric acid, adipic acid, gluconic acid, succinic acid, tartrate acid, fumaric acid, malic acid, phytic acid, ascorbic acid and salts thereof.
 飲料の温度20℃におけるpHは、3.5~4.6であることが好ましく、3.7~4.2であることがより好ましく、3.8~4.1であることがさらに好ましい。これにより、後味を良好に保持できる。pHの調整は、例えば、乳酸化合物の種類や量を調整することや、pH調整剤を用いることなどにより行うことができる。 The pH of the beverage at a temperature of 20 ° C. is preferably 3.5 to 4.6, more preferably 3.7 to 4.2, and even more preferably 3.8 to 4.1. This makes it possible to maintain a good aftertaste. The pH can be adjusted, for example, by adjusting the type and amount of the lactic acid compound, or by using a pH adjusting agent.
 飲料は、例えば、乳酸化合物、果糖、および必要に応じて添加されるその他の成分を、定法に従って水に均一に混合することで得ることができる。飲料は、加熱殺菌され、容器に詰められた状態の容器詰め飲料としてもよい。容器詰め飲料は、例えば、総量が100mL以上500mL以下の容器詰め飲料が挙げられる。各成分の調合タイミングは、殺菌処理前に限られず、特定の成分、例えば、揮発性が相対的に高い香気成分を殺菌処理後に調合してもよい。 Beverages can be obtained, for example, by uniformly mixing lactic acid compounds, fructose, and other components added as needed with water according to a conventional method. The beverage may be a packaged beverage that has been sterilized by heating and packed in a container. Examples of the packaged beverage include a packaged beverage having a total volume of 100 mL or more and 500 mL or less. The timing of blending each component is not limited to before the sterilization treatment, and a specific component, for example, an aroma component having a relatively high volatility may be blended after the sterilization treatment.
 容器としては、ガラス、紙、プラスチック(ポリエチレンテレフタレート等)、アルミ、およびスチール等の単体もしくはこれらの複合材料または積層材料からなる密封容器が挙げられる。また、容器の種類は、特に限定されるものではないが、たとえば、ペットボトル、アルミ缶、スチール缶、紙パック、チルドカップ、瓶等が挙げられる。取扱性、流通性、携帯性等の観点から、容器は紙パックまたはペットボトルであることが好ましい。 Examples of the container include a sealed container made of a single substance such as glass, paper, plastic (polyethylene terephthalate, etc.), aluminum, and steel, or a composite material or laminated material thereof. The type of container is not particularly limited, and examples thereof include PET bottles, aluminum cans, steel cans, paper packs, chilled cups, and bottles. From the viewpoint of handleability, distribution, portability, etc., the container is preferably a paper pack or a PET bottle.
 飲食品および飲食品組成物は、筋活動の活性化、筋疲労の軽減、抗疲労、持久力向上等の保健用途が表示された飲食品および飲食品組成物として提供・販売されることが可能である。このような表示は特に限定されないが、例えば「運動のパフォーマンスを向上する」、「運動による疲労感を軽減する」、「運動中、運動後の筋痙攣、こむら返り(いわゆる「つり」)を予防、軽減、改善する」、「仕事や勉強による疲労感を軽減する」、「記憶力を維持・向上する」、「注意力を維持・向上する」、「集中力を維持・向上する」、等が挙げられる。「表示」行為には、需要者に対して上記用途を知らしめるための全ての行為が含まれ、上記用途を想起・類推させ得るような表現であれば、表示の目的、表示の内容、表示する対象物・媒体等の如何に拘わらず、全て本発明の「表示」行為に該当する。 Foods and drinks and food and drink compositions can be provided and sold as foods and drinks and food and drink compositions labeled with health uses such as activation of muscle activity, reduction of muscle fatigue, anti-fatigue, and improvement of endurance. Is. Such indications are not particularly limited, but for example, "improve exercise performance", "reduce the feeling of fatigue caused by exercise", "prevent muscle cramps during and after exercise, and leg cramps (so-called" fishing "). "Reduce and improve", "Reduce the feeling of fatigue caused by work and study", "Maintain / improve memory", "Maintain / improve attention", "Maintain / improve concentration", etc. Be done. The act of "displaying" includes all actions for informing the consumer of the above-mentioned use, and if the expression is such that the above-mentioned use can be recalled or inferred, the purpose of the display, the content of the display, and the display are used. Regardless of the object, medium, etc., all fall under the "display" act of the present invention.
 「表示」には、健康食品、機能性食品、経腸栄養食品、特別用途食品、保健機能食品、特定保健用食品、栄養機能食品、機能性表示食品、医薬用部外品等としての表示も挙げられる。この中でも特に、消費者庁によって認可される表示、例えば特定保健用食品、栄養機能食品、もしくは機能性表示食品に係る制度、またはこれらに類似する制度にて認可される表示等が挙げられる。具体的には、特定保健用食品としての表示、条件付き特定保健用食品としての表示、機能性表示食品としての表示、身体の構造や機能に影響を与える旨の表示、疾病リスク減少表示、科学的根拠に基づいた機能性の表示等を挙げることができる。 "Indication" also includes labeling as health foods, functional foods, enteral nutrition foods, special purpose foods, health functional foods, specified health foods, nutritional functional foods, functionally labeled foods, non-medicinal products, etc. Can be mentioned. Among these, in particular, labeling approved by the Consumer Affairs Agency, for example, a system related to foods for specified health use, nutritionally functional foods, or foods with functional claims, or labeling approved by a system similar to these can be mentioned. Specifically, labeling as a food for specified health use, labeling as a food for specified health use with conditions, labeling as a food with functional claims, labeling to the effect that it affects the structure and function of the body, labeling for reducing disease risk, science The display of functionality based on the scientific basis can be mentioned.
 <剤>
 本発明に係る剤は、血中乳酸濃度上昇剤、抗疲労剤、持久力向上剤、筋活動活性化剤、または筋疲労低減剤である。
<Agent>
The agent according to the present invention is a blood lactate concentration increasing agent, an anti-fatigue agent, an endurance improving agent, a muscle activity activator, or a muscle fatigue reducing agent.
 本発明に係る血中乳酸濃度上昇剤(以下、単に「血中乳酸濃度上昇剤」ともいう。)は、乳酸化合物および果糖を有効成分として含む。ここで、有効成分として含むとは、血中の乳酸濃度を上昇させ得る有効量で含むことを意味する。乳酸化合物および果糖については、上述の飲食品に含まれる乳酸化合物および果糖の説明が適用される。 The blood lactic acid concentration increasing agent (hereinafter, also simply referred to as "blood lactic acid concentration increasing agent") according to the present invention contains a lactic acid compound and fructose as active ingredients. Here, including as an active ingredient means that it is contained in an effective amount that can increase the lactic acid concentration in blood. As for the lactic acid compound and fructose, the above description of the lactic acid compound and fructose contained in the food and drink is applied.
 血中の乳酸濃度を上昇させるとは、投与した個体の血中の乳酸濃度を、投与後、ある特定の時間における値を高くすることができること、または投与後のある一定の期間において高い値を維持することができること、の少なくとも一つの作用を有することを意味する。血中乳酸濃度上昇剤は、血中の乳酸濃度を上昇させることが知られている他の成分をさらに含むものであってもよい。 Increasing the blood lactate concentration means that the blood lactate concentration of the administered individual can be increased at a specific time after administration, or the value can be increased at a certain period after administration. It means having at least one action of being able to maintain. The blood lactate concentration increasing agent may further contain other components known to increase the blood lactate concentration.
 血中の乳酸は、筋活動の活性化および筋疲労の軽減に有効に作用することが知られている。したがって、血中乳酸濃度上昇剤は、スポーツ、トレーニング等の運動における筋活動の活性化を促す筋活動活性化剤としても、運動による筋疲労を軽減させる筋疲労軽減剤としても用いることができる。 Lactic acid in blood is known to act effectively on activating muscle activity and reducing muscle fatigue. Therefore, the blood lactate concentration increasing agent can be used both as a muscle activity activator that promotes activation of muscle activity in exercise such as sports and training, and as a muscle fatigue reducing agent that reduces muscle fatigue due to exercise.
 本発明に係る抗疲労剤(以下、単に「抗疲労剤」ともいう。)は、乳酸化合物および果糖を有効成分として含む。ここで、有効成分として含むとは、抗疲労作用を奏し得る有効量で含むことを意味する。乳酸化合物および果糖については、上述の飲食品に含まれる乳酸化合物および果糖の説明が適用される。抗疲労作用は、上述の飲食品における抗疲労作用の説明が適用される。本発明に係る抗疲労剤は、本発明に係る血中乳酸濃度上昇剤そのものであってもよく、血中乳酸濃度上昇剤と他の成分をさらに含むものであってもよく、他の成分としては抗疲労作用を有することが知られている他の成分が挙げられる。 The anti-fatigue agent according to the present invention (hereinafter, also simply referred to as "anti-fatigue agent") contains a lactic acid compound and fructose as active ingredients. Here, including as an active ingredient means that it is contained in an effective amount capable of exerting an anti-fatigue effect. As for the lactic acid compound and fructose, the above description of the lactic acid compound and fructose contained in the food and drink is applied. As for the anti-fatigue effect, the above description of the anti-fatigue effect in foods and drinks is applied. The anti-fatigue agent according to the present invention may be the blood lactate concentration increasing agent itself according to the present invention, or may further contain a blood lactate concentration increasing agent and other components, and may be used as other components. Includes other ingredients known to have anti-fatigue activity.
 本発明に係る持久力向上剤(以下、単に「持久力向上剤」ともいう。)は、乳酸化合物および果糖を有効成分として含む。ここで、有効成分として含むとは、持久力向上作用を奏し得る有効量で含むことを意味する。乳酸化合物および果糖については、上述の飲食品に含まれる乳酸化合物および果糖の説明が適用される。持久力向上作用は、上述の飲食品における持久力向上作用の説明が適用される。本発明に係る持久力向上剤は、本発明に係る血中乳酸濃度上昇剤そのものであってもよく、血中乳酸濃度上昇剤と他の成分をさらに含むものであってもよく、他の成分としては持久力向上作用を有することが知られている他の成分が挙げられる。 The endurance improving agent according to the present invention (hereinafter, also simply referred to as "endurance improving agent") contains a lactic acid compound and fructose as active ingredients. Here, including as an active ingredient means that it is contained in an effective amount capable of exerting an endurance improving effect. As for the lactic acid compound and fructose, the above description of the lactic acid compound and fructose contained in the food and drink is applied. As for the endurance improving action, the above-mentioned explanation of the endurance improving action in foods and drinks is applied. The endurance improving agent according to the present invention may be the blood lactate concentration increasing agent itself according to the present invention, may further contain a blood lactate concentration increasing agent and other components, and may be another component. Examples include other components known to have an endurance-enhancing effect.
 本発明に係る筋活動活性化剤(以下、単に「筋活動活性化剤」ともいう。)は、本発明に係る血中乳酸濃度上昇剤、抗疲労剤、または持久力向上剤そのものであってもよく、血中乳酸濃度上昇剤と他の成分をさらに含むものであってもよく、他の成分としては筋活動を活性化させることが知られている他の成分が挙げられる。 The muscle activity activator according to the present invention (hereinafter, also simply referred to as “muscle activity activator”) is the blood lactate concentration increasing agent, the anti-fatigue agent, or the endurance improving agent itself according to the present invention. It may further contain a blood lactate concentration increasing agent and other components, and other components include other components known to activate muscle activity.
 本発明に係る筋疲労軽減剤(以下、単に「筋疲労軽減剤」ともいう。)は、本発明に係る血中乳酸濃度上昇剤、または抗疲労剤そのものであってもよく、血中乳酸濃度上昇剤と他の成分をさらに含むものであってもよく、他の成分としては筋疲労を抑制させることが知られている他の成分が挙げられる。 The muscle fatigue reducing agent according to the present invention (hereinafter, also simply referred to as “muscle fatigue reducing agent”) may be the blood lactate concentration increasing agent or the anti-fatigue agent itself according to the present invention, and may be the blood lactate concentration. It may further contain an elevating agent and other components, and other components include other components known to suppress muscle fatigue.
 血中乳酸濃度上昇剤、抗疲労剤、持久力向上剤、筋活動活性化剤、および筋疲労軽減剤の投与経路としては、例えば、経口投与、経腸投与等の非経口投与が挙げられ、血中乳酸濃度上昇剤の投与剤形としては、例えば、噴霧剤、カプセル剤、錠剤、顆粒剤、シロップ剤、乳剤、座剤、注射剤、軟膏、テープ剤等が挙げられる。血中乳酸濃度上昇剤、抗疲労剤、持久力向上剤、筋活動活性化剤、および筋疲労軽減剤の有効成分である乳酸化合物および果糖の投与量は、剤形、投与対象の症状、年齢、体重等によって異なるが、血中の乳酸濃度を効果的に上昇させるためには、成人1人1回当たり、乳酸化合物が乳酸換算で3g以上75g以下、果糖が7g以上150g以下の投与量であることが好ましい。投与対象としては、哺乳動物が例示される。哺乳動物としては、ヒト、ウシ、ヒツジ、ヤギ、ブタ、イヌ、ネコ、ウマ等が挙げられる。 Examples of the route of administration of the blood lactic acid concentration increasing agent, anti-fatigue agent, endurance improving agent, muscle activity activator, and muscle fatigue reducing agent include parenteral administration such as oral administration and enteral administration. Examples of the dosage form of the blood lactic acid concentration increasing agent include sprays, capsules, tablets, granules, syrups, emulsions, suppositories, injections, ointments, tapes and the like. The doses of lactic acid compounds and fructose, which are the active ingredients of blood lactate concentration-increasing agents, anti-fatigue agents, endurance enhancers, muscle activity activators, and muscle fatigue-reducing agents, are determined by the dosage form, symptoms to be administered, and age. In order to effectively increase the blood lactic acid concentration, the dose of lactic acid compound should be 3 g or more and 75 g or less and lactic acid should be 7 g or more and 150 g or less per adult. It is preferable to have. Mammals are exemplified as the administration target. Examples of mammals include humans, cows, sheep, goats, pigs, dogs, cats, horses and the like.
 製剤化にあたっては、賦形剤、結合剤、崩壊剤、滑沢剤、安定剤、矯味矯臭剤、希釈剤、注射剤用溶剤等の添加剤を使用できる。製剤化する場合、製剤中の乳酸化合物および果糖のそれぞれの含有量は、剤形にもよるが、好ましくは1~50質量%であり、特に好ましくは3~30質量%である。 For formulation, additives such as excipients, binders, disintegrants, lubricants, stabilizers, flavoring agents, diluents, and solvents for injections can be used. In the case of formulation, the content of each of the lactic acid compound and fructose in the formulation is preferably 1 to 50% by mass, particularly preferably 3 to 30% by mass, although it depends on the dosage form.
 賦形剤としては、例えば、結晶セルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース、カルボキシメチルセルロースカルシウム等のセルロース誘導体;アラビアゴム;デキストラン;プルラン;軽質無水珪酸、合成珪酸アルミニウム、メタ珪酸アルミン酸マグネシウム等の珪酸塩誘導体;リン酸カルシウム等のリン酸塩誘導体;炭酸カルシウム等の炭酸塩誘導体;硫酸カルシウム等の硫酸塩誘導体等が挙げられる。 Examples of excipients include cellulose derivatives such as crystalline cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxymethyl cellulose, and carboxymethyl cellulose calcium; gum arabic; dextran; purulan; light anhydrous silicic acid, synthetic aluminum silicate, magnesium aluminometasilicate. And the like; silicate derivatives such as calcium phosphate; carbonate derivatives such as calcium carbonate; sulfate derivatives such as calcium sulfate.
 結合剤としては、例えば、上記賦形剤の他、ゼラチン;ポリビニルピロリドン;マグロゴール等が挙げられる。 Examples of the binder include gelatin; polyvinylpyrrolidone; tunagor and the like in addition to the above-mentioned excipients.
 崩壊剤としては、例えば、上記賦形剤の他、クロスカルメロースナトリウム、カルボキシメチルスターチナトリウム、架橋ポリビニルピロリドン等の化学修飾されたデンプンまたはセルロース誘導体等が挙げられる。 Examples of the disintegrant include, in addition to the above-mentioned excipients, chemically modified starch or cellulose derivatives such as croscarmellose sodium, carboxymethyl starch sodium, and crosslinked polyvinylpyrrolidone.
 滑沢剤としては、例えば、タルク;ステアリン酸;ステアリン酸カルシウム、ステアリン酸マグネシウム等のステアリン酸金属塩;コロイドシリカ;ビーガム、ゲイロウ等のワックス類;硼酸;グリコール;フマル酸、アジピン酸等のカルボン酸類;安息香酸ナトリウム等のカルボン酸ナトリウム塩;硫酸ナトリウム等の硫酸類塩;ロイシン;ラウリル硫酸ナトリウム、ラウリル硫酸マグネシウム等のラウリル硫酸塩;無水珪酸、珪酸水和物等の珪酸類;デンプン誘導体等が挙げられる。 Examples of the lubricant include talc; stearic acid; stearic acid metal salts such as calcium stearate and magnesium stearate; colloidal silica; waxes such as bee gum and gay wax; boric acid; glycol; carboxylic acids such as fumaric acid and adipic acid. Carboxylic acid sodium salt such as sodium benzoate; Sulfate salt such as sodium sulfate; Leucine; Lauryl sulfate such as sodium lauryl sulfate and magnesium lauryl sulfate; Silic acid such as anhydrous silicic acid and silicic acid hydrate; starch derivative etc. Can be mentioned.
 安定剤としては、例えば、メチルパラベン、プロピルパラベン等のパラオキシ安息香酸エステル類;クロロブタノール、ベンジルアルコール、フェニルエチルアルコール等のアルコール類;塩化ベンザルコニウム;無水酢酸;ソルビン酸等が挙げられる。 Examples of the stabilizer include paraoxybenzoic acid esters such as methylparaben and propylparaben; alcohols such as chlorobutanol, benzyl alcohol and phenylethyl alcohol; benzalkonium chloride; acetic anhydride; sorbic acid and the like.
 矯味矯臭剤としては、例えば、甘味料、酸味料、香料等が挙げられる。
 注射剤用溶剤としては、例えば、水、エタノール、グリセリン等が挙げられる。
Examples of the flavoring agent include sweeteners, acidulants, and fragrances.
Examples of the solvent for injection include water, ethanol, glycerin and the like.
 <組成物、組成物の製造における乳酸化合物および果糖の使用>
 本発明に係る組成物は、血中乳酸濃度上昇用組成物、抗疲労用組成物、持久力向上用組成物、筋活動活性化用組成物、または筋疲労低減用組成物である。本発明に係る組成物の製造においては、乳酸化合物および果糖が使用される。乳酸化合物および果糖については、上述の飲食品に含まれる乳酸化合物および果糖の説明が適用される。
<Use of lactic acid compounds and fructose in the production of compositions and compositions>
The composition according to the present invention is a composition for increasing blood lactate concentration, a composition for anti-fatigue, a composition for improving endurance, a composition for activating muscle activity, or a composition for reducing muscle fatigue. Lactic acid compounds and fructose are used in the production of the composition according to the present invention. As for the lactic acid compound and fructose, the above description of the lactic acid compound and fructose contained in the food and drink is applied.
 本発明に係る血中乳酸濃度上昇用組成物は、上述の血中乳酸濃度上昇剤を含むものであり、上述の血中乳酸濃度上昇剤そのものであってもよい。本発明に係る抗疲労用組成物は、上述の抗疲労剤を含むものであり、上述の抗疲労剤そのものであってもよい。本発明に係る持久力向上用組成物は、上述の持久力向上剤を含むものであり、上述の持久力向上剤そのものであってもよい。本発明に係る筋活動活性化用組成物は、上述の筋活動活性化剤を含むものであり、上述の筋活動活性化剤そのものであってもよい。本発明に係る筋疲労低減用組成物は、上述の筋疲労低減剤を含むものであり、上述の筋疲労低減剤そのものであってもよい。 The composition for increasing the blood lactate concentration according to the present invention contains the above-mentioned blood lactate concentration increasing agent, and may be the above-mentioned blood lactate concentration increasing agent itself. The anti-fatigue composition according to the present invention contains the above-mentioned anti-fatigue agent, and may be the above-mentioned anti-fatigue agent itself. The composition for improving endurance according to the present invention contains the above-mentioned endurance improving agent, and may be the above-mentioned endurance improving agent itself. The composition for activating muscle activity according to the present invention contains the above-mentioned muscle activity activator, and may be the above-mentioned muscle activity activator itself. The composition for reducing muscle fatigue according to the present invention contains the above-mentioned muscle fatigue reducing agent, and may be the above-mentioned muscle fatigue reducing agent itself.
 本発明に係る組成物の形態としては、例えば、医薬品組成物、飲食品組成物、および飼料組成物が挙げられる。医薬組成物の場合は、例えば、乳酸化合物および果糖とともに薬学的に許容され得る賦形剤等の任意の添加剤を添加して所望の剤形に製剤化することにより製造することが好ましい。飲食品組成物の場合は、上述の飲食品組成物の形態の説明が適用される。 Examples of the form of the composition according to the present invention include a pharmaceutical composition, a food and drink composition, and a feed composition. In the case of a pharmaceutical composition, it is preferable to prepare the pharmaceutical composition by adding any additive such as a pharmaceutically acceptable excipient together with a lactic acid compound and fructose to formulate the desired dosage form. In the case of a food or drink composition, the above description of the form of the food or drink composition is applied.
 飼料組成物としては、例えばペットフード、家畜飼料および養魚飼料等が挙げられる。飼料組成物は、一般的な飼料またはその原料、例えば穀類、粕類、糠類、魚粉、骨粉、油脂類、脱脂粉乳、ホエー、鉱物質飼料、および酵母類等に、乳酸化合物および果糖を混合することにより製造することができる。製造された飼料組成物は、一般的な哺乳動物、家畜類、養魚類、および愛玩動物等に経口的に投与することが可能である。 Examples of the feed composition include pet food, livestock feed, fish feed and the like. The feed composition is prepared by mixing a lactic acid compound and fructose with a general feed or its raw materials such as grains, lees, brans, fish meal, bone meal, fats and oils, skim milk powder, whey, mineral feed, and yeasts. It can be manufactured by doing so. The produced feed composition can be orally administered to general mammals, livestock, fish farms, pet animals and the like.
 <血中の乳酸濃度を上昇させる方法、抗疲労方法、持久力向上方法、筋活動を活性化させる方法、筋疲労を軽減させる方法>
 本発明に係る、血中の乳酸濃度を上昇させる方法、抗疲労方法、持久力向上方法、筋活動を活性化させる方法、および筋疲労を軽減させる方法は、乳酸化合物および果糖を哺乳動物に投与する工程を含む。乳酸化合物および果糖が投与されて、乳酸化合物および果糖が同じタイミングで体内に存在することにより、血中の乳酸濃度を上昇させることができる、抗疲労作用を発現させることができる、持久力を増強させることができる、筋活動を活性化させることができる、または筋疲労を低減させることができる。哺乳動物としては、ヒト、ウシ、ヒツジ、ヤギ、ブタ、イヌ、ネコ、ウマ等が挙げられる。
<Method of increasing blood lactic acid concentration, anti-fatigue method, endurance improvement method, muscle activity activation method, muscle fatigue reduction method>
The method for increasing the blood lactic acid concentration, the anti-fatigue method, the endurance improving method, the method for activating muscle activity, and the method for reducing muscle fatigue according to the present invention are to administer a lactic acid compound and fructose to a mammal. Including the process of When the lactic acid compound and fructose are administered and the lactic acid compound and fructose are present in the body at the same timing, the concentration of lactic acid in the blood can be increased, the anti-fatigue effect can be exhibited, and the endurance is enhanced. Can be lactic acid, can activate muscle activity, or can reduce muscle fatigue. Examples of mammals include humans, cows, sheep, goats, pigs, dogs, cats, horses and the like.
 以下、実施例を挙げて本発明をより詳細に説明するが、本発明はこれらに限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.
 <試験例A>
 [飲料]
 乳酸化合物および果糖を水に添加して、表1に示す量の乳酸(乳酸化合物の乳酸換算の合計量)および果糖を含む、総量が200mlの飲料1~7を調製した。乳酸化合物の原料としては、乳酸パウダー(コービオンジャパン(株)製)、乳酸カルシウム粉末(コービオンジャパン(株)製)、乳酸ナトリウム液(コービオンジャパン(株)製)、乳酸カリウム液(コービオンジャパン(株)製)を用い、これらを、乳酸換算の合計量が表1に示す値であり、かつ飲料のpHが3.7以上4.0以下となるように適宜用いた。乳酸換算の合計量を以下、単に「乳酸」の含有量とする場合がある。果糖の原料としては純果糖(加藤化学(株)製)を用いた。
<Test Example A>
[Beverage]
Lactic acid compounds and fructose were added to water to prepare beverages 1 to 7 having a total amount of 200 ml containing the amounts of lactic acid (total amount of lactic acid compounds in terms of lactic acid) and fructose shown in Table 1. As raw materials for lactic acid compounds, lactic acid powder (manufactured by Corbion Japan Co., Ltd.), calcium lactate powder (manufactured by Corbion Japan Co., Ltd.), sodium lactate solution (manufactured by Corbion Japan Co., Ltd.), potassium lactate solution (co. Bion Japan Co., Ltd.) was used, and these were appropriately used so that the total amount in terms of lactic acid was the value shown in Table 1 and the pH of the beverage was 3.7 or more and 4.0 or less. The total amount in terms of lactic acid may be simply referred to as the content of "lactic acid" below. Pure fructose (manufactured by Kato Chemical Co., Ltd.) was used as a raw material for fructose.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 [試験例1~7]
 試験例1~7において、それぞれ飲料1~7を被験者に摂取させて、本発明に係る飲料の経口摂取による血中乳酸濃度に及ぼす効果を確認した。健康な男女3名(年齢は30~60歳)を被験者とし、試験例1~7において同じ3名の被験者を用いた。試験例1~7は、それぞれ異なる日に行った。
[Test Examples 1 to 7]
In Test Examples 1 to 7, the subjects were allowed to ingest the beverages 1 to 7, respectively, and the effect of oral ingestion of the beverage according to the present invention on the blood lactate concentration was confirmed. Three healthy men and women (ages 30 to 60 years) were used as subjects, and the same three subjects were used in Test Examples 1 to 7. Test Examples 1 to 7 were performed on different days.
 (試験例1)
 温度24℃、相対湿度50%の測定室において、被験者は座った状態で測定を受けた。被験者は4時間絶食した後に、指先から採血し、血中乳酸濃度をアークレイ社製の測定装置(製品名:ラクテート・プロ2LT-1730)にて測定した。その後、被験者は、飲料1を摂取した。そして、飲料1の摂取後10分毎に60分経過後まで、上記と同様の方法にて血中乳酸濃度を測定した。なお、被験者は、飲料1を摂取後、60分経過後までは絶食とした。測定結果に基づき、各被験者について血中乳酸濃度が2mol/L以上を持続した時間(10分刻み)を算出し、3名の被験者の平均時間を算出した。表2に結果を示す。
(Test Example 1)
In a measuring room with a temperature of 24 ° C. and a relative humidity of 50%, the subject received the measurement while sitting. After fasting for 4 hours, the subject collected blood from the fingertips and measured the blood lactate concentration with a measuring device manufactured by ARKRAY (product name: Lactate Pro 2 LT-1730). After that, the subject ingested the beverage 1. Then, the blood lactate concentration was measured every 10 minutes after ingestion of the beverage 1 until 60 minutes had passed by the same method as described above. The subject was fasted until 60 minutes after ingesting the beverage 1. Based on the measurement results, the time (in 10-minute increments) at which the blood lactate concentration was maintained at 2 mol / L or higher was calculated for each subject, and the average time of the three subjects was calculated. The results are shown in Table 2.
 (試験例2~7)
 試験例2~7は、試験例1で用いた飲料1に代えて、それぞれ飲料2~7を用いて試験例1と同様の試験を行った。その後、試験例1と同様に3名の被験者の平均時間を算出した。表2に結果を示す。
(Test Examples 2 to 7)
In Test Examples 2 to 7, the same tests as in Test Example 1 were carried out using beverages 2 to 7, respectively, instead of the beverage 1 used in Test Example 1. Then, the average time of the three subjects was calculated in the same manner as in Test Example 1. The results are shown in Table 2.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 表2に示す結果から、果糖7g以上と乳酸3g以上とを含む飲料2~5を摂取した場合には、乳酸を含まない飲料1を摂取した場合、果糖を含まない飲料6を摂取した場合、及び果糖の含有量が5.0gである飲料7を摂取した場合と比較して、血中の乳酸濃度が2mmol/L以上である時間が長く、血中の乳酸濃度上昇に優れた効果があることがわかった。 From the results shown in Table 2, when the beverages 2 to 5 containing 7 g or more of fructose and 3 g or more of lactic acid were ingested, the beverage 1 containing no lactic acid was ingested, and the beverage 6 containing no lactic acid was ingested. And, as compared with the case of ingesting the beverage 7 having a fructose content of 5.0 g, the time when the lactic acid concentration in the blood is 2 mmol / L or more is longer, and there is an excellent effect in increasing the lactic acid concentration in the blood. I understand.
 [試験例8~10]
 試験例8~10において、それぞれ飲料1,3,6を被験者に摂取させて、その後運動を課し、本発明に係る飲料の経口投与による血中乳酸濃度に及ぼす効果を確認した。健康な男女3名(年齢は30~60歳)を被験者とした。試験例8~10において、同じ3名の被験者を用いた。試験例8~10は、それぞれ異なる日に行った。
[Test Examples 8 to 10]
In Test Examples 8 to 10, the subjects were ingested the beverages 1, 3 and 6, respectively, and then exercise was applied, and the effect of oral administration of the beverage according to the present invention on the blood lactic acid concentration was confirmed. The subjects were three healthy men and women (ages 30 to 60 years). In Test Examples 8 to 10, the same three subjects were used. Test Examples 8 to 10 were performed on different days.
 (試験例8)
 温度24℃、相対湿度50%の測定室において行い、被験者は座った状態で測定を受けた。被験者は2時間以上絶食した後に指先から採血し、血中乳酸濃度をアークレイ社製の測定装置(製品名:ラクテート・プロ2LT-1730)にて測定した。その後、被験者には、飲料1を摂取させ、低強度の自転車エルゴメータ運動を60分間課した。そして、飲料1の摂取後10分毎に60分経過後まで、上記と同様の方法にて血中乳酸濃度を測定した。測定結果に基づき、各被験者について血中乳酸濃度が4mmol/L以上を持続した時間(10分刻み)を算出し、3名の被験者の平均時間を算出した。表3に結果を示す。
(Test Example 8)
The measurement was performed in a measurement room having a temperature of 24 ° C. and a relative humidity of 50%, and the subject received the measurement while sitting. After fasting for 2 hours or more, the subject collected blood from the fingertips and measured the blood lactate concentration with a measuring device manufactured by ARKRAY (product name: Lactate Pro 2 LT-1730). The subject was then ingested Beverage 1 and subjected to low intensity bicycle ergometer exercise for 60 minutes. Then, the blood lactate concentration was measured every 10 minutes after ingestion of the beverage 1 until 60 minutes had passed by the same method as described above. Based on the measurement results, the time (in 10-minute increments) at which the blood lactate concentration was maintained at 4 mmol / L or higher was calculated for each subject, and the average time of the three subjects was calculated. The results are shown in Table 3.
 (試験例9,10)
 試験例9,10は、試験例8で用いた飲料1に代えて、それぞれ飲料3,6を用いて試験例8と同様の試験を行った。その後、試験例8と同様に3名の被験者の平均時間を算出した。表3に結果を示す。
(Test Examples 9 and 10)
In Test Examples 9 and 10, the same test as in Test Example 8 was performed using beverages 3 and 6, respectively, instead of the beverage 1 used in Test Example 8. Then, the average time of the three subjects was calculated in the same manner as in Test Example 8. The results are shown in Table 3.
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
 表3に示す結果から、果糖および乳酸を含む飲料3を摂取した場合には、乳酸を含まない飲料1及び果糖を含まない飲料6を摂取した場合と比較して、運動時の血中の乳酸濃度が4mmol/L以上である時間が長く、運動時の血中の乳酸濃度上昇において優れた効果があることがわかった。 From the results shown in Table 3, when the beverage 3 containing fructose and lactic acid was ingested, the lactic acid in the blood during exercise was compared with the case where the beverage 1 without lactic acid and the beverage 6 without fructose were ingested. It was found that the concentration was 4 mmol / L or more for a long time, and that it had an excellent effect on increasing the blood lactate concentration during exercise.
 <試験例B>
 試験例Bにおいて、それぞれ表4に示す3種類の飲料B1,B2,B3を被験者に摂取させて、本発明に係る飲料の経口摂取による運動による疲労に対する抗疲労効果、運動における持久力向上効果を評価した。飲料B2の調製には、粉末水あめ(昭和産業(株)製のM-SPD-M)を用い、飲料B3の調製には、乳酸化合物の原料として乳酸パウダー(コービオンジャパン(株)製の発酵乳酸パウダー60)、乳酸カルシウム粉末(コービオンジャパン(株)製の発酵乳酸カルシウム)、乳酸ナトリウム液(コービオンジャパン(株)製の発酵乳酸ナトリウム60%)、乳酸カリウム液(コービオンジャパン(株)製のPurasal(登録商標) HiPure P Plus)を用い、果糖の原料としては純果糖(加藤化学(株)製)を用いた。
<Test Example B>
In Test Example B, the subjects were allowed to ingest the three types of beverages B1, B2, and B3 shown in Table 4, respectively, to obtain an anti-fatigue effect against fatigue caused by oral ingestion of the beverage according to the present invention and an effect of improving endurance in exercise. evaluated. Powdered water candy (M-SPD-M manufactured by Showa Sangyo Co., Ltd.) was used to prepare beverage B2, and lactic acid powder (fermented by Corbion Japan Co., Ltd.) was used as a raw material for lactic acid compounds to prepare beverage B3. Lactate powder 60), calcium lactate powder (fermented calcium lactate manufactured by Corbion Japan Co., Ltd.), sodium lactate solution (60% fermented sodium lactate manufactured by Corbion Japan Co., Ltd.), potassium lactate solution (Corbion Japan Co., Ltd.) ), Puresal (registered trademark) HiPure P Plus) was used, and pure lactate (manufactured by Kato Chemical Co., Ltd.) was used as a raw material for lactate.
 健康な男女4名(年齢は25~60歳)を被験者とし、各被験者ともランダムな順序で表4に示す3種類の飲料を摂取するクロスオーバー式に実施した。温度24℃、相対湿度50%の測定室において試験を実施した。被験者は2時間以上の絶食後、自転車エルゴメータ(コンビ社製PowerMax VII、無酸素パワーテスト)にて最大発揮パワー(以下、「P1」ともいう)を測定し、その10分後からPWC(最大負荷量)の75%強度、60rpmにて一定強度の自転車運動をオールアウトまで、または60分まで負荷した。運動終了後安静として、直後に被験飲料をさせ、さらに60分後に再び最大発揮パワー(以下、「P2」ともいう)を測定した。表4に、異なる3種の被験飲料のP1に対するP2の割合の平均値を示す。 Four healthy men and women (ages 25 to 60 years old) were used as subjects, and each subject took a crossover method in which they ingested the three types of beverages shown in Table 4 in a random order. The test was carried out in a measuring room having a temperature of 24 ° C. and a relative humidity of 50%. After fasting for 2 hours or more, the subject measured the maximum exerted power (hereinafter, also referred to as "P1") with a bicycle ergometer (PowerMax VII manufactured by Combi, anoxic power test), and 10 minutes later, PWC (maximum load). (Amount) 75% intensity, constant intensity bicycle exercise at 60 rpm was loaded up to all-out or up to 60 minutes. Immediately after the exercise was completed, the test drink was given as a rest, and 60 minutes later, the maximum exerted power (hereinafter, also referred to as “P2”) was measured again. Table 4 shows the average value of the ratio of P2 to P1 of the three different test beverages.
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
 表4において、p<0.1を表し、p値は飲料B3と比較した結果である。表4に示す結果から、飲料B3の摂取は、水(飲料B1)やデキストリンを含む飲料(飲料B2)の摂取に対して、運動60分後の最大発揮パワー低下が小さく、筋疲労が低減されている、もしくは運動パフォーマンスの低下が抑制されていることが明らかであり、運動による疲労に対する抗疲労効果および運動における持久力向上効果を奏することがわかった。 In Table 4, * p <0.1 is represented, and the p value is the result of comparison with the beverage B3. From the results shown in Table 4, the intake of beverage B3 has a smaller decrease in maximum exerted power after 60 minutes of exercise and a reduction in muscle fatigue compared to the intake of water (beverage B1) and a beverage containing dextrin (beverage B2). It is clear that the decrease in exercise performance is suppressed, and it is found that the effect of anti-fatigue against fatigue caused by exercise and the effect of improving endurance in exercise are exhibited.
 <試験例C>
 試験例Cにおいて、それぞれ表5に示す3種類の飲料C1,C2,C3を被験者に摂取させて、本発明に係る飲料の経口摂取による精神的活動による疲労に対する抗疲労効果を評価した。飲料C2,C3の調製には、乳酸化合物の原料として乳酸パウダー、乳酸カルシウム、乳酸ナトリウム、乳酸カリウム(いずれもコービオンジャパン(株)製)を用い、果糖の原料としては純果糖(加藤化学(株)製)を用いた。
<Test Example C>
In Test Example C, the subjects were allowed to ingest the three types of beverages C1, C2, and C3 shown in Table 5, respectively, and the anti-fatigue effect against fatigue due to mental activity due to oral ingestion of the beverage according to the present invention was evaluated. Lactic acid powder, calcium lactate, sodium lactate, and potassium lactate (all manufactured by Corbion Japan Co., Ltd.) are used as raw materials for lactic acid compounds, and pure fructose (Kato Kagaku (Kato Kagaku)) is used as a raw material for fructose to prepare beverages C2 and C3. Co., Ltd.) was used.
 健康な男女7名(年齢は25~60歳)を被験者とし、各被験者ともランダムな順序で3種類の飲料を摂取するクロスオーバー式に実施した。温度24℃、相対湿度50%の測定室において試験を実施した。被験者は2時間以上の絶食後、認知課題として、内田クレペリンテストを15分間、並びにパソコン上で実施するATMTを15分間実施させ、それぞれ課題の正当数、実施数を測定した(摂取前測定値)。その5分後に被験飲料を摂取させた後、さらに内田クレペリンテスト、ATMT、各15分間を再び実施させ、それぞれの課題の正当数、実施数を測定した(摂取後測定値)。表5に摂取後測定値の摂取前測定値からの変化量の7名の被験者の平均値を示す。 Seven healthy men and women (ages 25 to 60 years old) were the subjects, and each subject ingested three types of beverages in a random order in a crossover manner. The test was carried out in a measuring room having a temperature of 24 ° C. and a relative humidity of 50%. After fasting for 2 hours or more, the subjects were asked to perform the Uchida-Kraepelin test for 15 minutes and ATMT performed on a personal computer for 15 minutes as cognitive tasks, and measured the correct number and number of tasks, respectively (measured values before ingestion). .. Five minutes later, the test beverage was ingested, and then the Uchida-Kraepelin test and ATMT were performed again for 15 minutes each, and the correct number and number of each task were measured (measured values after ingestion). Table 5 shows the average value of the change in the measured value after ingestion from the measured value before ingestion of 7 subjects.
 また、被験飲料の摂取前の認知課題測定前、および、被験飲料の摂取後の認知課題測定後に質問(VAS(Visual Analog Scale))を行い自己評価させた。VASは、100mmの線分上に現在の状態を縦線で記入するものであり、0mmをその状態に関して全くなく、100mmを経験しうる最大とする。表5に、疲労度、注意力、集中力の3項目について、認知課題の実施前に対する実施後の自己評価の変化量の平均値を示す。 In addition, questions (VAS (Visual Analog Scale)) were asked before the measurement of the cognitive task before ingestion of the test beverage and after the measurement of the cognitive task after ingestion of the test beverage, and self-evaluation was performed. In the VAS, the current state is written by a vertical line on a line segment of 100 mm, and 0 mm is not related to the state at all, and 100 mm is the maximum that can be experienced. Table 5 shows the average value of changes in self-evaluation before and after the cognitive task for the three items of fatigue, attention, and concentration.
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
 表5において、p<0.1を表し、p値は飲料C3と比較した結果である。表5に示す結果において、飲料C3は、水(飲料C1)や乳酸を含むものの果糖を含まない飲料(飲料C2)の摂取に対して、精神的活動による疲労度の上昇が小さく、注意力、集中力の低下が抑制され、また、内田クレペリンテスト、ATMTともに、課題成績の上昇が大きかった。表5に示す結果から、飲料C3による抗疲労効果、持久力向上効果を奏することがわかった。 In Table 5, * p <0.1 is represented, and the p value is the result of comparison with the beverage C3. In the results shown in Table 5, the beverage C3 has a small increase in the degree of fatigue due to mental activity with respect to the intake of water (beverage C1) and the beverage containing lactic acid but not fructose (beverage C2). The decrease in concentration was suppressed, and the increase in task performance was large in both the Uchida Kleperin test and ATMT. From the results shown in Table 5, it was found that the beverage C3 exerts an anti-fatigue effect and an endurance improving effect.

Claims (14)

  1.  乳酸化合物および果糖を含み、
     前記乳酸化合物の含有量が乳酸換算で3g以上75g以下であり、
     前記果糖の含有量が7g以上150g以下である、飲食品。
    Contains lactic acid compounds and fructose,
    The content of the lactic acid compound is 3 g or more and 75 g or less in terms of lactic acid.
    A food or drink having a fructose content of 7 g or more and 150 g or less.
  2.  乳酸化合物は、乳酸、乳酸カリウム、乳酸カルシウム、乳酸鉄、および乳酸ナトリウムからなる群より選択される1種以上である、請求項1に記載の飲食品。 The food or drink according to claim 1, wherein the lactic acid compound is at least one selected from the group consisting of lactic acid, potassium lactate, calcium lactate, iron lactate, and sodium lactate.
  3.  飲料、または飲料に調製して用いられる粉末飲料である、請求項1または2に記載の飲食品。 The food or drink according to claim 1 or 2, which is a beverage or a powdered beverage prepared and used as a beverage.
  4.  総量が100mL以上500mL以下の容器詰飲料である、請求項3に記載の飲食品。 The food or drink according to claim 3, which is a packaged beverage having a total volume of 100 mL or more and 500 mL or less.
  5.  乳酸化合物および果糖を含み、
     前記乳酸化合物の含有量が乳酸換算で0.6質量%以上30質量%以下であり、
     前記果糖の含有量が1.4質量%以上60質量%以下である、飲食品組成物。
    Contains lactic acid compounds and fructose,
    The content of the lactic acid compound is 0.6% by mass or more and 30% by mass or less in terms of lactic acid.
    A food or drink composition having a fructose content of 1.4% by mass or more and 60% by mass or less.
  6.  乳酸化合物および果糖を有効成分として含む、血中乳酸濃度上昇剤。 A blood lactic acid concentration increasing agent containing a lactic acid compound and fructose as active ingredients.
  7.  乳酸化合物および果糖を有効成分として含む、抗疲労剤または持久力向上剤である剤。 An agent that is an anti-fatigue agent or an endurance improving agent that contains a lactic acid compound and fructose as active ingredients.
  8.  筋活動活性化剤または筋疲労低減剤である、請求項7に記載の剤。 The agent according to claim 7, which is a muscle activity activator or a muscle fatigue reducing agent.
  9.  肉体疲労の抗疲労剤である、請求項7に記載の剤 The agent according to claim 7, which is an anti-fatigue agent for physical fatigue.
  10.  精神疲労の抗疲労剤である、請求項7に記載の剤。 The agent according to claim 7, which is an anti-fatigue agent for mental fatigue.
  11.  成人1人1回当たり、前記乳酸化合物が乳酸換算で3g以上75g以下、前記果糖が7g以上150g以下の投与量となるように用いられる、請求項7~10のいずれか1項に記載の剤。 The agent according to any one of claims 7 to 10, wherein the lactic acid compound is used in a dose of 3 g or more and 75 g or less and fructose is 7 g or more and 150 g or less per adult. ..
  12.  抗疲労用組成物、または持久力向上用組成物の製造における、乳酸化合物および果糖の使用。 Use of lactic acid compounds and fructose in the production of anti-fatigue compositions or endurance-enhancing compositions.
  13.  乳酸化合物および果糖を哺乳動物に投与する工程を含む、抗疲労方法。 An anti-fatigue method comprising the step of administering a lactic acid compound and fructose to a mammal.
  14.  乳酸化合物および果糖を哺乳動物に投与する工程を含む、持久力向上方法。 A method for improving endurance, which comprises a step of administering a lactic acid compound and fructose to a mammal.
PCT/JP2021/036738 2020-10-05 2021-10-05 Food and drink, anti-fatigue agent, and endurance improver WO2022075297A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022555490A JPWO2022075297A1 (en) 2020-10-05 2021-10-05

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-168454 2020-10-05
JP2020168454 2020-10-05

Publications (1)

Publication Number Publication Date
WO2022075297A1 true WO2022075297A1 (en) 2022-04-14

Family

ID=81126940

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/036738 WO2022075297A1 (en) 2020-10-05 2021-10-05 Food and drink, anti-fatigue agent, and endurance improver

Country Status (2)

Country Link
JP (1) JPWO2022075297A1 (en)
WO (1) WO2022075297A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019235489A1 (en) * 2018-06-04 2019-12-12 株式会社明治 Anti-fatigue composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019235489A1 (en) * 2018-06-04 2019-12-12 株式会社明治 Anti-fatigue composition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "II. Dietary habits of athletes", KNOWLEDGE OF SPORTS MEDICINE (REVISED EDITION), 1 February 2018 (2018-02-01), JP, pages 15 - 37, XP009535753 *
HIDAKA, NOBUE ET AL.: "251 Effect of pre-exercise lactate intake on glucose metabolism in rat endurance exercise", THE PROGRAM / ABSTRACTS OF 9TH ANNUAL MEETING OF THE JAPANESE SOCIETY OF EXERCISE PHYSIOLOGY; JULY 31 - AUGUST 1, 2001, JAPANESE SOCIETY OF EXERCISE PHYSIOLOGY, JP, 1 January 2001 (2001-01-01) - 1 August 2001 (2001-08-01), JP, pages 66, XP009535755 *
TAPPY LUC, ROSSET ROBIN: "Health outcomes of a high fructose intake: the importance of physical activity", THE JOURNAL OF PHYSIOLOGY, WILEY-BLACKWELL PUBLISHING LTD., GB, vol. 597, no. 14, 1 July 2019 (2019-07-01), GB , pages 3561 - 3571, XP055920157, ISSN: 0022-3751, DOI: 10.1113/JP278246 *

Also Published As

Publication number Publication date
JPWO2022075297A1 (en) 2022-04-14

Similar Documents

Publication Publication Date Title
JP3907964B2 (en) Mental fatigue reducing composition, concentration maintenance enhancing composition and mental vitality maintenance enhancing composition
US20130274350A1 (en) Novel sweetener having sucrose-like taste, method for producing the same, and use of the same
JP4931352B2 (en) Iron supplement and its use
JP4986413B2 (en) Composition for improving blood circulation
US8921310B2 (en) Method for accelerating mammalian body fat metabolism
WO2015137387A1 (en) Muscle enhancing drug
JP6942113B2 (en) Amino acid-containing composition
JP2006335725A (en) Composition for improving bloodstream
WO2021256077A1 (en) Cognitive function improving agent, cognitive function maintaining agent, hippocampus function improving agent, and hippocampus function maintaining agent
WO2021059755A1 (en) Composition for sympathetic nerve activation
JP6807083B2 (en) Muscle-building compositions and methods for building muscle
WO2022075297A1 (en) Food and drink, anti-fatigue agent, and endurance improver
JP2007031403A (en) Lactic acid production inhibitor
JP7373918B2 (en) Composition for regulating skin gas diffusion
JP2021063059A (en) Myalgia inhibitory composition and food and drink containing the same
CN111936155B (en) Composition for promoting secretion of FGF21
JP2009114112A (en) Anti-osteoporosis agent
JP4948056B2 (en) Fatigue prevention or improvement agent
JP6193176B2 (en) Vitality and / or concentration improver
JP2021093932A (en) Skin condition improving composition
JP2020105107A (en) Composition for reducing blood ucoc concentration
JP2021134156A (en) Basal metabolism-improving composition
JP2021023181A (en) Composition for promoting proliferation of specific bifidobacterium bacteria in human intestinal tract
JP2021024838A (en) Composition for promoting production of brain-derived neurotrophic factor in child
JP6052566B2 (en) Fatigue odor inhibitor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21877596

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022555490

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21877596

Country of ref document: EP

Kind code of ref document: A1